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ABSTRACT
EFFECTS OF PYCNOGENOL ON MICROSOMAL
CYTOCHROME P450 AND APOPTOSIS
by
Huong T. Huynh
Doctor of Philosophy, Graduate Program in Pharmacology
Loma Linda University, June 2000
Dr. Robert W. Teel, Chairman
Phytochemicals are naturally-occurring compounds found in plants, many
of which are consumed as nutritional supplements by humans. Pycnogenol is a
mixture of flavonoid compounds extracted from bark of pine trees (Pinus
maritima) and is commercially available in several different pharmaceutical
preparations as a free radical scavenger.
Since few scientific studies have documented the pharmacologic effects of
pycnogenol, our objective was to characterize the biological activity of
pycnogenol. One study looked at the effects of pycnogenol on the three
pathways of NNK metabolism: NNK reduction, N-oxidation and a-hydroxylation.
NNK is a lung carcinogen. Lung and liver microsomes from 6 mo and 20 mo old
male F344 rats were incubated with 3H-NNK in the presence of pycnogenol and
following intragastric administration of pycnogenol. Pycnogenol inhibited the in
vitro metabolism of NNK in both liver and lung microsomes from both age
groups. Intragastric administration of pycnogenol enhanced a-hydroxylation of
NNK in liver microsomes and N-oxidation of NNK in lung microsomes from either
age group.

x

Metabolic activation of NNK depends upon cytochrome P450 enzymes
(GYP). A second study looked at O-dealkylation of the substrates
benzyloxyresorufin (BROD), ethoxyresorufin (EROD) and methoxyresorufin
(MROD) linked to CYP2B1,2C6 and 1A2, respectively. Pycnogenol significantly
inhibited BROD, EROD and MROD activity in 6 mo and 20 mo liver microsomes
and inhibited BROD activity but enhanced EROD and MROD in both 6 mo and
20 mo lung microsomes. Following intragastric administration, pycnogenol
inhibited BROD, EROD and MROD in both 6 mo and 20 mo liver microsomes.
Pycnogenol inhibited MROD activity but enhanced EROD in 6 mo and 20 mo
lung microsomes. Results from Western blot analysis of expressed CYP2B1 and
CYP1A2 protein in lung and liver microsomes from pycnogenol-treated rats did
not correlate with the effects of O-dealkylation in these rats.
The effect of pycnogenol on apoptosis in cultured "normal" human
mammary (MCF-10) cells and human mammary cancer (MCF-7) cells in the
presence of pycnogenol was also investigated. At 80 |ng/ml pycnogenol,
apoptosis in MCF-7 cells was significantly increased but had no effect on
apoptosis in MCF-10 cells. We conclude that pycnogenol may afford protection
against NNK-induced lung cancer by modulating NNK metabolism and the
activity of cytochrome P450 enzymes. Pycnogenol may also selectively induce
apoptosis in cancer cells.

xi

CHAPTER ONE
INTRODUCTION
A. Physiology of aging
Several prominent anatomical and physiological changes in the body have
been observed during aging. Some of these changes include a reduction in
stature, an increase in fat deposition, which peaks at about age 50, weight loss
between age 50-70 and a decline in weight of organs with age. Other changes
often detected with aging are a decline in brain weight, an increase in heart
weight, possibly to compensate for its declining functional activity, and a
decrease in bone weight.
Several theories of aging have been proposed. The molecular theory
suggests that aging is due to external causes or environmental insults from food
and toxins, bacteria and viruses, and radiation and pollutants. The free radical
theory assumes that aging is due to cellular and molecular changes in the
membrane, cytoplasm and nucleus. Changes in the membrane lead to altered
fluidity, permeability, and transport

(1,61)

. Changes in the cytoplasm, such as

accumulation of free radicals and lipofuscin, cross-linkage of aged collagen and
defective cellular functions caused by overuse also contribute to aging. The
accumulation of free radicals formed by oxidative reactions damages
membranes, cytoplasm, and the nucleus, whereas the accumulation of lipofuscin
causes a loss of cytoplasmic mass, mitochondrial numbers, and rough
endoplasmic reticulum often associated with cellular aging. Changes in the
nucleus can result (a) from codon restriction, in which there is loss of accuracy
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during the translation of mRNA, (b) from DNA damage and failure in repair
mechanisms, and (c) from changes in the expression of genes regulating
development and aging (61).
The cell membrane is about 50 A thick containing proteins, lipids, and
carbohydrates. At physiological temperatures, hydrocarbon chains of lipids are
relatively fluid and the bulk of lipids are in a liquid-crystalline state. The
membrane is semi-permeable to molecules and ions that penetrate by simple or
facilitated diffusion. The membrane is also capable of active transport, allowing
for passage of molecules and ions against their concentration gradient. In the
membrane, there is an increase in the number of microvilli with age in specific
cell types. Microvilli are important in increasing membrane transport. Their
increase in number may be a compensation for decreased function. With aging,
membrane lipids are susceptible to peroxidation and membrane fluidity is
markedly altered by free radical accumulation (74). The fluid mosaic model
describes the cell as having membrane components that are able to diffuse
laterally within the membrane. Changes in membrane fluidity may induce
alterations in membrane excitability, transport, and receptor binding, leading to
changes in response to endogenous and exogenous stimulation. The formation
of receptor-ligand complexes diminishes with age. Other effects observed with
age include accumulation of lipofuscin, alteration of enzymes, peroxidation of
intracellular membranes, and decreased ion conductance (74).
Within the cytoplasm, the mitochondria are the most prominent
organelles. Mitochondria extract energy by oxidation of chemical bonds in
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nutrients. In the cristae and studded on the exterior surface of the mitochondria
are packets of microsomal enzymes. The most notable changes in the cytoplasm
with aging are the decreased number of mitochondria in neurons, in presynaptic
terminals of neuromuscular junctions, and in liver and heart cells. Mitochondrial
size however increases in some cells (74). Ames and colleagues have reported
that mitochondrial functions decline with age (1). They have observed that
oxidants generated by mitochondria appear to be a major source of the oxidative
lesions that accumulate with age. Accumulation of such damage may contribute
to aging and age-associated degenerative diseases. Age-associated
accumulation of oxidative damage to mitochondrial DNA correlates with the level
of mitochondrial DNA deletions seen in a number of tissues composed of
postmitotic cells, suggesting that oxidative damage to DNA leads to mutations
that result in dysfunctional mitochondria(1).
In addition to changes in the plasma membrane and mitochondria, other
functional changes have been observed in aging cells and tissues. The
invagination in the endoplasmic reticulum (ER) increases the surface area and
allows for exchanges within the cytoplasm. Depending on the animal species,
the activities of several enzymes may decrease, increase, or remain unchanged
with aging. Activities of the antioxidant enzymes, superoxide dismutase and
catalase, decrease significantly in the liver of old rats but can be returned to
normal by dietary restriction (74). Oxidative damage is one of the possible
mechanisms capable of altering proteins and enzymes during aging. Cell
degeneration reflects altered structure and impaired function. Infiltration, or
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entrance into the cell of substances that are usually kept out, often accompanies
cell degeneration (74).
Oxygen is an essential component for the survival of aerobic organisms.
Although oxygen is required in oxidative phosphorylation and in mitochondrial
electron transport systems, its metabolites cause potentially damaging effects to
biological systems including the nervous system, eye, cardiovascular system,
skin, lung, and liver(14). Oxygen toxicity results from the presence of reactive
oxygen intermediates produced during the reduction of molecular oxygen to
water. The two most important oxygen radicals are superoxide anion (02’) and
the highly reactive hydroxyl radical (*OH)

(6.8,14)

. Weakly reactive nitric oxide

(NO’), hypochlorous acid (HCIO), and ozone (03) also cause cellular damage
(23)

. Hydrogen peroxide (H2O2) decomposes to #OH. Free radicals attack other

molecules indiscriminately, produce oxygen-consuming chain reactions and
cause fragmentation or cross-linkage of molecules (45). Radiological studies
indicate that hydroxyl radicals abstract a hydrogen atom from DMA to form
carbon-centered radicals. Subsequent reaction with oxygen forms peroxyl
radical adducts of DMA. Hydroxyl radicals can also reduce double bonds to form
DMA adducts. Superoxide anion causes DMA strand scission while H2O2
liberates DMA bases, changing their chemical structures and causing DNA
strand breaks. The consequences of oxidative radical damage to DNA are
chromosomal damage, mutation and transformation into cancer cells, and cell
death

(14,62,64)

. Lipid hydroperoxides, products of lipid breakdown, are unstable

and can produce radicals upon reaction with transition metal ions (14).
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Metabolites of unsaturated fatty acid lipid peroxidation cause cell damage by
disrupting membrane structure, causing loss of membrane integrity and cellular
functions.
Proteins composed of thiol-containing amino acids would be susceptible
to free radical damage, resulting in altered enzymatic activities. The major free
radical damages to proteins are cleavage of peptide bonds and fragmentation of
polypeptide chains. Less drastic protein damage involves conformational
changes that lead to aggregation, loss of protein function, and increased
proteolytic turnover

(14,62)

. Oxidation of thiol groups would inactivate enzymes

involved in maintaining membrane integrity and functioning of normal cellular
processes

(64)

Two biological sources of reactive radicals are xanthine oxidase and
mitochondrial oxidation, which decreases with age (1). Xanthine oxidase
converts hypoxanthine to xanthine and xanthine to uric acid during purine
metabolism. The metabolism of hypoxanthine produces free radicals (44).
Studies in the intestine have suggested that ischemia promotes the conversion
of xanthine dehydrogenase to xanthine oxidase, which uses 02 as an electron
acceptor(44).
Mitochondrial oxidation involves the electron transport system (ETS),
which uses electron carriers to transfer electrons from an NAD+-oxidizable
substrate to 02. The rate of superoxide anion production by the mitochondrion
increases when the concentration of oxygen is increased or when the ETS
becomes largely reduced. Oxygen concentration can increase under hyperoxia.
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Production of free radicals results from high 02 concentrations and from
contribution of substrates from other biological pathways that yield electron
carriers (NAD+ and FAD) which pass electrons into the mitochondrial respiratory
chain. Such biological pathways include the tricarboxylic acid cycle, in which
succinate dehydrogenase reversibly converts succinate and FAD to fumarate
and FADH2. Fatty acid oxidation also yields NADH and FADH2 to donate
electrons into the respiratory chain. The final electron acceptor in the respiratory
chain is 02, which produces reactive radicals

(41,44)

Aerobic organisms have several antioxidant defense mechanisms to
neutralize the potentially cytotoxic effects of free radicals (55). Superoxide
dismutase (SOD) is an enzymatic defense mechanism against free radical
damage and functions by catalyzing the dismutation of 02' to H202 (6,8’55). The
activity of SOD essentially removes 02‘ from tissue to neutralize 02'-mediated
toxicity. Superoxide anion causes oxidation of iron-sulfur (Fe-S) complexes,
which are important in enzyme activities, electron transfer, and metabolism.
SOD scavenging activity thus provides protection of Fe-S complexes against
oxidation by 02'. Superoxide anion reacts with nitric oxide (NO*) to form
peroxynitrite (ONOO ), a strong oxidizing agent that attacks sulfhydryl groups and
induces lipid peroxidation. Peroxynitrite also induces oxidation of deoxyribose
sugars and catalyzes the nitration of tyrosine and phenolic compounds. SOD
metabolism of 02‘ inhibits the formation of ONOO' and attenuates tissue
damage. Although SOD removes 02' and ONOO' from biological systems, the
dismutation of 02' also produces H202. However, H202 is less cytotoxic than
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ONOO'(55) and is neutralized by catalase and glutathione peroxidase to form 02
and H2O2

(8,41,55)

Non-enzymatic antioxidants include a-tocopherol, ubiquinol-10,
glutathione, and uric acid. cc-Tocopherol is an *OH scavenger. Ubiquinol-10 is
an electron carrier in the ETS. Both a-tocopherol and ubiquinol-10 can break the
chain reaction of lipid peroxidation (55). Uric acid scavenges 'OH and inhibits
xanthine oxidase

(41,55)

. Vitamins E and C and carotenes can donate H+ to lipids

and free radicals to stop the peroxidation cycle.

B. Cancer and Chemoprevention
The stages and regulations of the cell cycle have been previously
reviewed

(36)

. In adult somatic cells, Gi is the first growth phase, during which

cells prepare for DNA synthesis and replication. DNA replication occurs during
the S phase. A second growth phase follows during which the cell prepares for
mitosis. Mitosis begins with the condensation of genetic material into visible
chromosomes and the formation of the mitotic spindle. Once aligned on the
mitotic spindle, the chromosomes and nuclear content will segregate towards
opposite poles in the cell. Cytokinesis will pinch the cell membrane to form two
daughter cells (36). The new daughter cells can either enter G1 and divide or
enter a resting phase G0. A daughter cell may enter G1 and the cell cycle from
G0 if stimulated by growth factors. There are two checkpoints, late in G1 and at
the end of G2, at which the cell checks its progress to determine whether to stop
or continue to the next phase in the cell cycle. The combined interaction
7

between exogenous stimuli (hormones, growth factors, and cytokines) and
endogenous factors (cell size, protein content, and calcium concentration) can
push the cell through the Gi checkpoint to enter the S phase and DNA synthesis.
The second checkpoint allows the cell to proofread DNA transcription and to
correct for mutations before entering mitosis (36).
Normal cells undergo mitosis and reproduction when the cells come into
contact with nearby cells. In contrast, cancer cells do not respond to signals that
control proliferation; thus reproduction of cancer cells goes unregulated. Cancer
cells also migrate and invade secondary tissues (80). Most carcinogens have in
common an ability to interact with genomic DNA and to potentially alter the
regulatory sequences controlling genes that encode structural proteins and
enzymes that modulate cell proliferation and differentiation. Several phenotypic
alterations commonly observed in cancer cells are represented in Figure 1. In
general, cancer tissues, compared to normal counterparts, contain cells with
larger nuclei and more prominent nucleoli, are dedifferentiated and have
increased number of cells undergoing mitosis (58). Cancer cells are not
proliferating faster than normal cells, but there is a higher number of cancer cells
actively dividing while fewer of them are in the G0 resting stage of the cell cycle.
Enzymatic activity is often increased in cancer cells. Changes in cell surface of
cancer cells include a change in charge density due to redistribution of
glycoproteins, glycolipids, and phospholipids (58). As a result of these surface
changes, cell function decreases due to a decrease in the complete processing
of carbohydrates, altered lectin agglutinability, modified adhesion properties and
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Figure 1. Phenotypic alterations in transformed cells. (Modified from
Ruddon, 1990).

9

production of tumor-associated antigens. An increased propensity of tumor cells
to shed lytic enzymes such as glycosidases, proteases, and collagenases have
also been observed

(58)

1. Cancer and Apoptosis
There are two types of cell death. Necrosis is an accidental cell death
caused by extrinsic factors. Loss of membrane integrity and death of groups of
cells, commonly caused by hypoxia, are characteristic of necrosis. Other
features of necrosis are the loss of ion regulation and homeostasis, cell swelling
and lysis. Rupture of cell membranes causes release of lysosomal enzymes and
cytoplasmic and nuclear content. Intracellular materials attract neutrophils and
macrophages, resulting in phagocytosis of necrotic tissue and inflammation (18).
In contrast, apoptosis is a programmed cell death, genetically regulated
and can be caused by stimuli that trigger signal transduction pathways leading to
death of individual cells. Apoptosis regulates loss of specific cells during normal
embryonic development (dedifferentiation, cell maturation, immunological
functions) and eliminates mutated or damaged cells that are potentially fatal to
the organism

(18,69)

. Morphological changes during apoptosis are marked with

chromatin condensation and aggregation with cell shrinkage (Figure 2). After
chromatin aggregation, the nucleus fragments, forming membrane-bound
apoptotic bodies

(68,69)

. Apoptosis is distinct from necrosis in that apoptosis is not

associated with inflammation but apoptotic cells are recognized and engulfed by
phagocytic cells and macrophages (51). Characteristics that distinguish apoptosis

10

Figure 2. Cell undergoing apoptosis.
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from necrosis include intact membrane integrity such that cellular contents are
not released to stimulate inflammatory responses and exposure of
phosphatidylserine on the cell surface. Other notable features of apoptosis
include detachment from the extracellular matrix, loss of cell surface microvilli
and junctional complexes, activation of sphingomyelinases and release of
phosphatidylcholine and ceramide

(18,59)

Apoptosis is an evolutionarily conserved regulatory process that has been
studied extensively in Caenorhabditis elegans as well as in mammals (69). In
vitro studies indicate that apoptosis occurs rapidly. DNA is nicked and cleaved
into fragments of multiples of 180-200 base pairs. DNA fragmentation is
characteristic of apoptosis and is irreversible. Apoptosis can be triggered by
several factors including Ca2+ influx, free radicals, certain viruses, tumor necrosis
factors, growth factors, hormone withdrawal, chemotherapeutic agents, radiation,
and heat shock

(18,59,72)

. Studies by McConkey et al have demonstrated that

DNA fragmentation and cell death occurs in conjunction with increased Ca2+ in
thymocytes (43).
The process of apoptosis can be divided into sequential phases beginning
with stimulus or ligand activation of cellular receptors, which activate signal
transduction pathways. Intracellular signal transduction is often coupled to Gprotein-dependent protein kinase or to tyrosine kinase pathways. After activation
of a signal transduction, cellular response may vary from mitosis, differentiation,
or apoptosis. Genes are constituents of the DNA molecule of the chromosomes
and contain information that, when activated, can control cellular response to
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stimuli. Changes in the genes can change the activity or response of the cell(80).
Two classes of genes play important roles in triggering cancer. Proto-oncogenes
stimulate cell growth while tumor suppressor genes inhibit cell functions.
Mutation of proto-oncogenes can lead to carcinogenic oncogenes and increase
proliferation of cancer cells. Mutation of tumor suppressor genes will inactivate
these genes, resulting in loss of the ability to prevent inappropriate growth.
Several mutational events must occur and occur in critical genes for a cancer cell
to develop into a tumor mass (80). Inhibitory signals and mechanisms in the
malignant cells are either absent or inactive. In addition to normal tumor
suppressor genes, transforming growth factor (3 (TGFP) is an inhibitory
substance that can stop growth of various types of normal cells.
Investigations of C. elegans have revealed several regulatory
mechanisms of apoptosis. Fas (also called APO-1/CD95) is a cell surface
receptor and a member of the tumor necrosis factor and nerve growth factor
superfamily of receptors. These receptors contain a conserved amino acid
domain such that receptor activation will induce auto-dimerization of the domains
and trigger apoptosis

(17,18)

. Receptor-mediated cell death can also be triggered

by glucocorticoids in white blood cells. In reproductive tissues, the lack of
hormones (FSH, estradiol, and androgens) can stimulate apoptosis.
Studies of the nematode C. elegans have identified three genes (ced-3,
ced-4, ced-9) involved in apoptosis. Overexpression of ced-3 or ced-4 promotes
cell death

(18,51)

. The ced-3 gene encodes an aspartic acid-specific cysteine

protease and cleaves poly-(ADP-ribose) polymerase (PARP) during apoptosis.
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PARR senses DNA nicks during DNA repair. PARR also inhibits Ca2+/Mg2+dependent endonucleases that cause DNA fragmentation (18,51). Cleavage of
PARP by ced-3 inhibits DNA repair and activates apoptosis. Ced-9 is
responsible for cell survival. Overexpression of ced-9 prevents apoptosis. It has
been suggested that both ced-3 and ced-9 interact with ced-4. Binding of ced-9
to ced-4 prevents ced-4 from interacting with ced-3. Binding of ced-3 to ced-4
activates apoptosis (18).
In the mammalian system, interleukin-1 p-converting enzyme (ICE) is the
functional homologue of ced-3. ICE is a caspase enzyme that triggers a
proteolytic cascade leading to apoptosis. Caspases are cytosolic aspartatespecific cysteine proteases. The bcl-2 gene is the mammalian homologue of
ced-9, which blocks cell death. In the mouse model, it has been shown that
overexpression of bcl-2 protects cells from apoptosis, suggesting that bcl-2
inhibits the execution of cell death in mammals. Bax is a member of the bcl-2
multigene family containing genes that can both inhibit and stimulate apoptosis.
High levels of bax can overcome the bc/-2 suppression of apoptosis, thus
increasing apoptosis. p53 is a tumor suppressor gene and a transcription factor
that can also regulate apoptosis. p53 is involved in DNA repair such that when a
cell has damaged DNA, p53 stops the cell cycle at G0/G1. If the damage is
irreparable, p53 induces bax transcription to stimulate cell death (18).
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Stage 1. Genetic mutation in a
single cell (orange) within a
population of normal cells (beige).

Stage 2. Altered cell undergoes
hyperplasia. Over time, a single
cell (pink) acquires additional
mutation(s).

Stage 3. During dysplasia, the
mutated cells may appear
abnormal shape and orientation.
Over time, a new mutation may
occur (purple).

Stage 4. In situ cancer
continues abnormal growth
but has not penetrated
underlying tissue.

Stage 5. Tumor mass invades
underlying tissue, sheds cells
into blood or lymph, and
metastasizes.

Figure 3. Stages of tumor development. (Modified from Weinberg, 1996).
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2. Cancer and Chemoprevention
Scientific investigations over the past 20 years have provided a better
understanding of the fundamental principles of cancer development.
Carcinogenesis is a multi-step process involving exposure of target cells to
chemicals, oncogenic viruses, and radiation, followed by accumulation of genetic
changes and progression of tumor development. We know that a tumor arises
from a common ancestral cell, which has undergone unregulated reproduction
and has accumulated genetic mutations. Tumor development occurs in stages.
Figure 3 is a schematic of tumor development in epithelial tissues. The first
stage involves the acquisition of genetic mutations by a stem cell within a normal
population. These genetic mutations increase the propensity of the cells to
proliferate abnormally. Hyperplasia follows, in which the mutated cell and its
descendants appear normal but are reproducing when the cells should be at rest
in the cell cycle. Hyperplasia may persist for many years but a subsequent
critical mutation may cause a loss of control of normal cell growth, leading to
dysplasia. During dysplasia, descendant cells appear abnormal in shape and
orientation. Again, some time may pass before another mutation event occurs.
An in situ cancer may remain indefinitely at its site of origin, however some cells
may continue to acquire genetic changes that allow the tumor to invade
underlying tissue and enter the circulatory system. Once in the circulation, these
malignant cells can metastasize to other parts of the body(80).
Chemoprevention is the use of chemical compounds, either synthetic
pharmaceutical agents or naturally occurring constituents of foods in the diet, to
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control the occurrence of chronic diseases including cancer and cardiovascular
disease. There are two major categories of chemopreventive agents. The first is
anti-initiating agents, which block the metabolic activation of carcinogens. The
second category is the antipromoting agents, which inhibit the expression of
altered genes and prevent DNA damage (46). Other investigators have reported
that naturally occurring compounds, such as polyphenols, flavonoids, and
catechins found in fruits, vegetables, and grains, possess beneficial effects
against carcinogenesis. Phenolic compounds such as ellagic acid and gallic
acid, lignans, and phytic acids are found in grains and can inhibit the formation of
carcinogenic metabolites {67). Several animal studies have shown that a diet high
in vegetables, fruits, and grains and low in fat can reduce the risk of certain
cancers. Some human studies have confirmed the protective effect of fruits and
vegetables against cancers of the stomach, colon, and lung (67).
Some of the health benefits and effects of fruits, vegetables, and grains
were reported at The Third International Congress on Vegetarian Nutrition, which
convened in March 1997. Many of the studies reported at this meeting
compared the general health of a vegetarian population to that of a population of
subjects who included meat and fat in the diet. Whole grains are a rich source of
phytic acid, antioxidants, and phytoestrogens. Consumption of whole grains, not
refined grains, may provide protective effects against cardiovascular disease,
cancer, and diabetes, although the exact mechanism remains unclear(63).
Clinical studies have shown that consumption of vegetable protein (low fat)
instead of animal protein (high fat) is associated with lowered triglyceride, low-
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density lipoproteins, and total cholesterol levels (2). The consumption of nuts
showed highly significant inverse association with the risk of myocardial
infarction and death due to ischemic heart disease (60). A review of recent
studies found that tea and its polyphenolic constituents can inhibit
carcinogenesis of various organ systems by blocking formation of nitroso
compounds, suppressing activation of carcinogens and trapping genotoxic
agents

(42,85)

. The antioxidant properties of tea provides protection against lipid

peroxidation, DNA strand breakage and formation of DNA adducts such as 8hydroxydeoxyguanosine (79). Green tea polyphenols inhibited induced
gastrointestinal carcinogenesis in rats (84).

C. Metabolism of Xenobiotics
1. Metabolism of xenobiotics by Cytochrome P450 enzymes
Cytochrome P450 (CYP) is a gene superfamily of hemoprotein with the
unique characteristic of catalyzing many different types of chemical reactions.
CYPs are characterized spectrophotometrically by their peak absorbance at 450
nm when the reduced hemeprotein reacts with and binds to carbon monoxide.
Over the past three decades, CYP research has progressed from its discovery
and characterization of the biochemical and biophysical properties and functions
to its purification and structural elucidation. The most well studied CYP enzyme
is the soluble bacterial CYPCam- Studies using CYPcam have advanced the
structure/function relationship of this superfamily of enzymes (20). Structural
analyses of CYPCam and other bacterial CYPs have revealed that CYPs are
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composed of two domains: one domain is mostly a-helices, contributing
approximately 70% of the protein, and the second domain is mostly p-sheets,
forming approximately 22% of the protein (20). CYP enzymes are found in the
microsomal fractions of the endoplasmic reticulum and mitochondria and can be
isolated from liver cells following homogenization and differential centrifugation
(21,39)

. The liver contains the highest concentration of total CYP of any organ (48).
The cytochrome P450 enzyme system is the detoxification mechanism in

the body, metabolizing endogenous substances, such as steroids, fatty acids,
fat-soluble vitamins, eicosanoids, and alkaloids as well as exogenous and
environmental substances, including carcinogens and pharmaceutical agents
(18,21)

. The detoxification systems involve Phase I reactions, which metabolizes

substrates into more water-soluble substances. Phase I reactions occur
primarily in the endoplasmic reticulum (ER), whereas Phase II reactions occur
mainly in the cytosol to conjugate substances into more excretable species (7).
The catalytic mechanism of CYP involves a cycle in which the CYP reductase
enzyme binds and oxidizes the substrate (Figure 4). When in the ferric state, the
hemeprotein core of the enzyme binds the substrate. An electron, or reducing
equivalents, is transferred from an electron-donating species, either NADPH or
cytochrome b5, to the iron atom of the hemeprotein, reducing the enzyme to the
ferrous state. After the ferrous hemeprotein binds molecular oxygen, a second
electron, along with a proton, is transferred to the iron atom (21). The reduction
and cleavage of molecular oxygen is rate-limiting (81). The dissociation of one
molecule of water yields a ferric oxide complex that oxidizes the substrate. The
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oxidized substrate is released, regenerating the ferric cytochrome P450 enzyme
to associate with another substrate and repeat the cycle. Cytochrome b5,
embedded in the ER membrane, can directly donate an electron to the CYP
enzyme. NADPH is located in the cytoplasm and donates an electron to the
membrane-bound cytochrome P450 reductase. Within the CYP reductase, the
electron is sequentially transferred from FMN to FAD, which donates the electron
to the CYP enzyme (21).
Cleavage of molecular oxygen can generate active oxygen species, which
react with the heme iron. Oxygen plays an important role in the decoupling
pathway of substrate metabolism that involves oxidation of NADPH without
substrate metabolism. It is proposed that superoxide can be released following
the first electron transfer in the CYP cycle (35). Superoxide dismutase
metabolizes superoxide to form hydrogen peroxide. Hydrogen peroxide can
account for the large consumption of reducing equivalents. The formation of
hydrogen peroxide also directly competes with oxygen cleavage. Two electrons
reduce active oxygen to form a water molecule. Early investigations suggest that
in both bacterial and mammalian systems, hydrogen peroxide is formed when
water is present in the active sites of the CYP enzyme during oxygen activation
(34)

. Overall, oxygen is important in the cytochrome P450 cycle as an electron

acceptor during the final step of substrate oxidation. Oxygen and its active
metabolites also compete for reducing equivalents during substrate oxidation,
which may be necessary to prevent rapid self-destruction of the CYP enzymes.

20

Oxidized
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Figure 4. Cytochrome P450 Cycle. (Modified from
Guengerich, 1993).
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Changes in dietary intake of proteins, carbohydrates, and fats can
modulate the metabolic activities of CYP enzymes. In laboratory rats, increased
consumption of dietary proteins was inversely related to the development of
breast cancer, suggesting that a high protein diet may enhance CYP activity to
increase oxidative degradation of procarcinogens. Other studies have
determined that high protein intake correlated with increased hepatic microsomal
CYP content, liver weight, and mitotic indices (3). An increased consumption of
fat (a 20% corn oil diet) in laboratory rats was found to induce CYP2B1 and 2B2
while the induction of CYP2E1 remained unaffected (3). Substrates for CYP2B
include tobacco nitrosamines and substrates for CYP2E1 include ethanol. It has
been suggested that a diet high in polyunsaturated fatty acids might increase
fluidity of cellular membranes to facilitate CYP activation of carcinogens (3).
However the interrelationships of diet and carcinogens are complex and may be
affected by other factors. In comparison to high consumption of protein and fat,
a diet high in carbohydrates reduces oxidative metabolism in laboratory animals
because the carbohydrates tended to compete with xenobiotics for CYP binding
sites (3). Similar studies have been conducted on the effects of dietary
macronutrients on human microsomal metabolism. Studies of healthy men
revealed no difference in drug clearances in subjects with high fat and high
carbohydrate intakes. High protein consumption however showed increased
metabolism of drugs such as propranolol and theophylline (3).
Many investigators have reported effects of modulating CYP enzyme
activity by exogenous compounds. Using male and female Wistar rats, Kato and
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Takanaka reported that microsomal activity decreased in old animals (600 days)
compared to young animals (100 days). Their results suggested gender
differences, in which male rats had higher enzyme activity than female rats of the
same age (32). Total CYP content was higher in males than in females and
higher in young animals compared to older animals (33), suggesting that young
animals may have higher microsomal enzyme activity. The metabolism of
promutagens, such as 2-aminoanthracence and aflatoxin

(AFBi) by liver

microsomes from male Lou rats of different ages increased from age 3 weeks to
10 months, but then declined in old age. Metabolism of benzo(a)pyrene (BaP)
however was not altered (28). Turmeric and curcumin are spices and coloring
agents extracted from the plant Curcuma longa. In a study using mouse liver S9
microsomes, curcumin and turmeric were shown to inhibit, in a dose dependent
manner, the formation of BaP-derived DNA adducts. Curcumin-free aqueous
turmeric extracts did not inhibit formation of such adducts

(16)

Flavonoids are a family of compounds found in fruits, vegetables, tea,
seeds, bark, leaves, nuts, and flowers. Obermeier and colleagues have reported
that tangeretin, green tea flavonoids and other flavonoids can inhibit microsomal
metabolism of 7-ethoxyresorufin and 7-pentoxyresorufin (50). Ethoxyresorufin Odeethylase (EROD) is primarily catalyzed by CYP1A1 in rat liver and by CYP1A2
in human. Hepatic hydroxylation of p-nitrophenol and demethylation of
erythromycin were inhibited by flavonoids at high concentrations (50). It has been
previously shown in Wistar rats that in the lung ethoxyresorufin is metabolized
most rapidly by CYP1A1, pentoxyresorufin is metabolized by CYP2B1 and
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benzyloxyresorufin is metabolized by CYP1A1,2B1, and 3A1 (76). Chlorophyllin,
a derivative of the plant pigment chlorophyll, is a potent inhibitor of DNA
adduction by AFBi

(9,86)

. In liver microsomes from human and male Sprague-

Dawley rats, chlorophyllin dose-dependently inhibited several CYP-dependent
enzymes including EROD, benzyloxyresorufin O-debenzylase (BROD), 7ethoxycoumarin O-deethylase, 7-coumarin hydroxylase, BaP 3-hydroxylase,
chlorzoxazone 6-hydroxylase, and nifedipine oxidation (86). Garlic organosulfur
compounds such as diallylsulfides and allylsulfides suppress hydroxylation of pnitrophenol by CYP2E1

(35,56)

. Tea polyphenols (catechin, epigallocatechin and

epigallocatechin gallate) generally inhibit enzyme activity, however there are
suggestions that green tea extracts can selectively enhance the activity of
methoxyresorufin O-demethylase (MROD) and pentoxyresorufin O-dealkylase
(PROD), as indicated by increases in protein levels of CYP1A2 and CYP4A1 (10).
Such contradictory findings suggest that CYP enzyme activities differ with
substrate and between species.

2. Metabolism of the tobacco-specific nitrosamine NNK
The nitrosamine 4-(methynitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is
an abundant and potent pulmonary carcinogen found in tobacco(13). NNK also
induces formation of tumors in the liver, nasal mucosa, trachea, and pancreas
(13)

. Tobacco smoke contains nicotine and other biologically active substances

such as the carcinogen BaP and large amounts of oxygen radical-forming
compounds (4). Nicotine is converted into NNK via reaction with a nitrosyl cation.
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Nitrosyl cation (NO ) may be donated from sodium nitrite (NaN02), found in
natural food as well as food additives and used to enhance flavor. The
intermediate compound formed from this nitrosylation reaction is chemically
stable at low temperature however, upon burning the cigarette, the intermediate
decomposes to form NNK (78).
NNK requires metabolic activation by microsomal enzymes (Figure 5)
(25.31)

. Carbonyl reduction of NNK yields NNAL, a potent pulmonary carcinogen

(pathway a). Detoxification of NNK and NNAL occurs by N-oxidation to form
NNK-N-oxide and NNAL-N-oxide (pathway b). The major metabolic activation
pathway of NNK is a-carbon hydroxylation (pathway c). a-Methylene
hydroxylation of NNK (pathway c, left) leads to formation of keto aldehyde and
methyldiazohydroxide. Keto aldehyde is metabolized into excretable
compounds. Methyldiazohydroxide can methylate or pyridyloxobutylate DNA or
proteins to form DNA or protein adducts. a-Methyl hydroxylation of NNK
(pathway c, right) produces diazohydroxide and formaldehyde (25). The
diazohydroxide can react with water to form keto alcohol or with DNA or proteins
to form DNA or protein adducts (13). NNK can also undergo denitrosation
reactions to form two a-nitrosamine radicals and nitrite radicals. The
consequence of radical formation is discussed in section A, Physiology of Aging.
It has been shown that tobacco smoke condensate crosses the placenta
and is a carcinogen in experimental animals (31), suggesting products of tobacco
smoke including NNK are potential transplacental carcinogens in humans.
Cigarette smoke contains more than 4000 individual chemicals, including BaP,
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Figure 5. Pathways of NNK metabolism. Pathway a shows
carbonyl reduction of NNK. Pathways b are N-oxidation of NNK
and NNAL. Pathways c are a-hydroxylation of NNK. (Modified from
Hecht et al, 1980).
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NNK, and oxygen radical forming compounds such as catechol and
hydroquinone

(4,31)

. A study of cancerous and non-cancerous lung tissue from

untreated lung cancer patients indicated a positive correlation between cigarette
smoking and the levels of 8-hydroxydeoxyguanosine, a type of oxidative DNA
damage (4). Formation of 06-methylguanine, following DNA pyridyloxobutylation,
inhibits DNA repair and increases the risk of tumor induction by NNK(53). As
shown in Figure 4, DNA damage can result from the methylation and
pyridyloxobutylation of DNA by metabolites formed during a-hydroxylation of
NNK

(26,53)

. A review of enzymes involved in NNK biotransformation indicate that

a-hydroxylation in rat and mouse lung is catalyzed by CYP2B1 and 2A1,
whereas in humans a-hydroxylation of NNK is catalyzed by CYP1A2

(22,25)

Smith and colleagues have studied the bioactivation of NNK in human lung
microsomes and have demonstrated that CYP1A1 and 2A6 are active in the
oxidation of NNK

(65)

The works of many investigators suggest that NNK metabolism can be
modulated by dietary factors. Isothiocyanates of variable chain length are found
in cruciferous vegetables and were shown to decrease a-hydroxylation of NNK
and to effectively inhibit NNK-induced lung and esophageal tumors (66’70). Green
tea polyphenols, the citrus oil d-limonene, the flavonoid catechin, and ellagic
acid, inhibited NNK metabolism. Such inhibition would suggest a potential
protective effect by such plant-based compounds against DNA damage and
tumor formation as a result of NNK metabolism (15>37>47).
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D. Immunoblotting Detection of Protein Expression
The use of electrophoresis techniques to detect DNA (Southern blotting)
and RNA (Northern blotting) have been established since the mid-1970s.
Southern and Alwine et al have independently described blotting techniques
utilizing specific probes to detect DNA fragments and RNAs

(24 and references therein)

Methods to detect protein expression (Western blotting) was adapted from DNA
blotting techniques in which electrophoresed material from an agarose gel was
transferred onto a membrane for further analysis. In Western blotting, SDSpolyacrylamide gels are used to increase elution of protein during transfer from
gel to nitrocellulose membrane (24). The rate of transfer is dependent on the
molecular weight of proteins such that low molecular weight peptides deposit
onto the nitrocellulose membrane with higher efficiency than heavier molecular
weight proteins (11). Nitrocellulose membrane however has poor retention of low
molecular weight proteins and is fragile when dry. Development of
polyvinylidene difluoride (PVDF) membrane provides more strength than
nitrocellulose and does not require extensive blocking as seen with another
commonly used material such as nylon membranes (24). PVDF membranes do
require pretreatment in methanol prior to transferring. Once the transfer is
complete, the membrane may be probed utilizing selective antibodies to detect
protein of interest. The membrane is first probed using a primary antibody that
recognizes the antigen or the protein of interest residing on the membrane.
Many monoclonal or polyclonal primary antibodies are commercially available.
The membrane is then exposed to a secondary antibody.
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Chemiluminescence is the production of light resulting from a chemical
reaction. The reaction produces a molecule in its chemically excited state. As
the energy of this excited molecule decays and the molecule returns to its
ground state, energy is given off as light. Chemiluminescence in Western
blotting analysis is produced by the oxidation of luminol(30). Luminol (5-amino2,3-dihydro-1,4-phthalazinedione) is a commonly used liquid phase
chemiluminescent compound. Luminol is a cyclic diacylhydrazide. It has been
noted that a shift in the position of the amino group reduces the quantum
efficiency, which is associated with the intensity of luminescence (82).
Electrophilic substitution in the benzene ring decreases luminescence while
electrophobic substituents increase light production (82). Even though luminol is a
strong luminescent molecule, annelated analogs are shown to be 300% more
efficient(82). The incorporation of p-substituted phenols greatly enhances light
emission such that emission is a prolonged, relatively stable, and highly intense
glow (73) instead of an instantaneous flash

(82)

+ Light (425 nm)

Fig. 6. Chemical reaction of luminol.

Horseradish-peroxidase (HRP) catalyzes the oxidation of luminol in the
presence of hydrogen peroxide to produce a luminol radical. The luminol radical
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forms an endoperoxide which decomposes to yield an electronically excited 3aminophthalate dianion (Figure 6), and the dianion emits light on return to its
ground state (30’82). The light emitted is captured on autoradiographic film for
further analysis (83). Chemiluminescence may be increased by the presence of
chemical enhancers such as phenols, which act as electron-transfer mediators
between peroxidase and luminol

(73,83)

. Many Western blot detection kits

commercially available use the HRP-conjugated system. The intensity of
chemiluminescence from the luminol/hbCVHRP system is proportional to the
number of secondary antibody molecules and therefore the amount to antigen
retained on the membrane following protein transfer(30).
Luminescent assays have the advantage of being relatively inexpensive,
easy, and rapid procedures. Detection limits of chemiluminescence depend on
the sensitivity of light and the quantum efficiency of the reaction (82). However,
such luminescent immunoassays are nonspecific since luminol undergoes
chemiluminescent reactions in the presence of various oxidants (oxygen, iodine,
superoxide anion) other than hydrogen peroxide (82). The presence of reducing
agents such as uric acid may also interfere with the chemiluminescent reaction
(82)

. However, immunoassays utilizing HRP-conjugated systems provide an

alternative to radioactive labeling methods.
A problem that may arise in Western blotting is weak reactive bands that
are often indistinguishable from background noise. Weak reactive bands may be
caused by low antigen concentrations or by low affinity antibody binding (71).
Blocking agents including bovine serum albumin (BSA), casein, skimmed milk
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and Tween 20 (polyoxyethylene sorbitan monolaurate) are commonly used in
Western blotting (71). Tween 20 is a nonionic detergent and may remove proteins
from nitrocellulose or other transfer membranes (71). In a study comparing
various blocking agents and the effect on incubation temperature on background
staining, Thean and Toh showed that minimal background resulted from the use
of 0.1% Tween 20 and incubation temperature of 4° C (71). These investigators
have shown that antibodies bind faster at higher temperatures (22° C or 37° C),
however higher temperatures may also lead to higher background staining (71).
Therefore a compromise must be made to achieve the highest possible specific
antigen-antibody binding and an acceptable amount of background. It is
possible to incubate at 4° C to achieve low background but extend incubation
time to increase specific binding. It should be noted that blocking agents such
as BSA and casein contain immunoglobulins that may cross react with the
conjugated detection system used.

E. Pycnogenol
Pycnogenol is a mixture of flavonoids and polyphenols extracted from the
bark of conifers, particularly from maritime pine {Pinus maritima)(40). Few
published scientific studies have reported the pharmacologic properties of
pycnogenol. Pycnogenol is a free radical scavenger, with the ability to quench
hydroxy radicals to protect against oxidative damage (38-49). Pycnogenol also
protects against lipid peroxidation (57i75). At high concentrations, pycnogenol
inhibits nitric oxide accumulation by reducing formation of nitroso compounds (77).
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Flavonoids are benzo-y-pyrone derivatives found ubiquitously in plants and
impart color to flowers, fruits, and vegetables. Some systemic effects of
flavonoids include antiinfective, positive inotropic, sympathomimetic, and
antiinflammatory effects. Because pycnogenol contains flavonoids, it may
function by one or all of several mechanisns. As an antioxidant, flavonoids have
a high propensity to transfer electron and to be easily oxidized. Flavonoids are
also metal chelating agents with the ability to stop lipid oxidation by removing
Fe2+ and Cu+ ions involved in the Fenton reaction (Fe2+ + H2O2 -» Fe3+ + ’OH +
OH )(5). A third mechanism by which flavonoids act as an antioxidant is the
direct removal of oxygen free radicals (55). Certain flavonoids may also induce
apoptosis (12).
Flavonoids in foods are bound to sugars through p-glycosidic bonds, thus
making absorption of flavonoids negligible. There are no enzymes in the Gl tract
to cleave (3-glycosidic bonds however hydrolysis can occur by intestinal
microorganisms. Our understanding of the metabolism of flavonoids stems from
animal studies. The major sites of flavonoid metabolism are the liver and the
colonic microflora (29). Hydroxyl groups undergo O-methylation and conjugation
with glucuronic acid and sulfate in the liver. Bacterial ring fission occurs in the
colon and yields aglycones (free flavonoids without a sugar molecule that are
considered to be absorbable through gut wall)(29). Hydrolysis by colonic flora
produces phenolic acids, which may undergo secondary reactions (j3-oxidation,
reduction, demethylation, dehydroxylation, and decarboxylation). Phenolic acids
are absorbed and excreted in urine. The metabolism of flavonoids in humans
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has not been extensively studied however, absorption of various quercetin
preparations range between 17% to 52% (29).

F. Objectives
Few scientific studies have reported the physiologic and pharmacologic
properties of pycnogenol. However, for over 20 years, pycnogenol has been
available for public use as a dietary supplement in Europe, Australia, and some
countries in the Far East(52). Pycnogenol is sold in the United States and in
Europe as a micronutrient possessing disease-fighting properties such as
antioxidative and free radical scavenging effects. The tobacco-specific
nitrosamine 4-(methynitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a pulmonary
carcinogen. To investigate the effect of pycnogenol on lung and liver
carcinogenesis, we studied the following hypotheses:

1. Pycnogenol can inhibit the metabolism of NNK by lung and liver
microsomes from 6 and 20 mo male F344 rats.
2. Pycnogenol can inhibit the in vivo and in vitro activities of phase
I and phase II enzymes in lung and liver microsomes from 6 and
20 mo rats.
3. Pycnogenol can induce apoptosis in breast cancer cells.

Chapters 2-5 have been published in peer-reviewed journals. To clarify
whether the differences in inhibition of cytochrome P450 enzyme activities
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reported in Chapters 4 and 5 were due to the expression of cytochrome
P450 isoforms, we utilized immunoblotting analysis (Western) to
determine microsomal protein expression following administration of
pycnogenol to 6 mo and 20 mo rats. The results are presented in Chapter
6. Results of our apoptosis study are presented in Chapter 7. The data
presented in Chapters 2-7 are discussed in the final chapter, Chapter 8.
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ABSTRACT
NNK is a potent environmental carcinogen to which smokers and
nonsmokers are exposed. The response to NNK can be altered by various
factors including nutrition. In this study, we examined the effects of pycnogenol
on the in vitro metabolism of the tobacco-specific nitrosamine NNK by liver and
lung microsomes from 6 mo and 20 mo old male F344 rats. The major NNK
metabolic pathway in liver microsomes was carbonyl reduction while ochydroxylation was the major pathway in lung microsomes irrespective of age.
Pycnogenol (40 ^ig/ml, 120 ng/ml) exhibited a statistically significant inhibition of
carbonyl reduction and a-hydroxylation pathways in liver microsomes from both
age groups and in addition to these pathways, pycnogenol inhibited the Noxidation pathway in lung microsomes. The liver and lung microsomes from 20
mo rats were less active than from 6 mo rats although the difference was not
statistically significant.
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1. INTRODUCTION
The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone (NNK) forms during the curing and processing of tobacco by the
nitrosation of nicotine [3]. NNK is present in cigarette smoke [8]. Estimates put
the American smoker at daily exposures of 2 jug of NNK [9]. NNK is in
environmental tobacco smoke to which nonsmokers are exposed [2]. It is a
potent carcinogen in laboratory animals and its specificity for the lung has
implicated it as an etiological agent in lung cancer in smokers [11,12].
Cytochrome P450 enzymes metabolize NNK into reactive metabolites that
have mutagenic and carcinogenic properties [5,11]. The crucial step of
metabolic activation involves hydroxylation of the two carbons bound to the Nnitroso group to form reactive electrophilic species which methylate and
pyridyloxobutylate purine bases of DNA [23]. The cytochrome P450 isozymes
associated with metabolic activation of NNK include 2B1, 1A1, 1A2, 2D6, and
2E1 [5,6,16,30]. These isozymes are species and tissue specific [1].
It is important to identify chemical compounds of natural or synthetic origin
that can inhibit the metabolic activation of NNK and thus protect against lung
cancer in smokers who choose to continue tobacco use. Pycnogenol is a
mixture of compounds present in the bark of maritime pine trees [20]. This
mixture includes oligomeric and monomeric procyanidins and phenols.
Pycnogenol has been used as a dietary supplement because of its putative free
radical scavenging properties [24]. Few scientific studies of pycnogenol have
been reported.
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The aim of this study was to investigate the effects of pycnogenol on the
metabolic activation of NNK by liver and lung microsomes of Fisher 344 male
rats as a function of age. The information obtained is useful in determining
whether pycnogenol possesses chemopreventive properties and whether animal
age affects the metabolism of NNK and its response to pycnogenol.

2. MATERIALS AND METHODS
2.1 Chemicals
NADP+, glucose-6-phosphate and glucose-6-phosphate dehydrogenase
were purchased from Sigma Chemical Co. (St. Louis, MO). [5-3H] NNK (2.51
Ci/mmol) was obtained from Chemsyn Science (Lenexa, KS). NNK metabolites
used as reference standards were prepared as described [25].
2.2 Preparation of microsomes
Male F344 rats ages 6 mo and 20 mo were purchased from Charles River
Laboratory (Wilmington, ME). They were sacrificed by C02 asphixiation and
livers and lungs were removed. Organs were homogenized in 2 vol 0.25 M TrisHCI (pH 7.4). Microsomes were isolated by differential centrifugation [19],
resuspended in 0.25 M Tris-HCI buffer and stored in one ml aliquots at -80° C.
Protein content was determined [18].
2.3 Assays of NNK Metabolism
The effects of pycnogenol on the metabolism of NNK by liver and lung
microsomes from 6 mo and 20 mo F344 rats were studied using a modification
of a previously described procedure [25]. Incubation mixtures contained 5 mM
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glucose-6-phosphate, 1.5 units glucose-6-phosphate dehydrogenase, 1 mM
NADP+, 1 mM EDTA, 3 mM MgCI2, 3 |iCi [5-3H] NNK, 40 ng or 120 ng
Pycnogenol and 5 mM sodium bisulfite in a final volume of one ml. Following
incubation at 37° C for 10 min, the reaction was started by adding 0.5 mg of liver
or lung microsomal protein. The mixtures were incubated for 30 min in triplicate
in a shaking waterbath at 37° C. Reactions were stopped by the addition of 200
[il each of 25% zinc sulfate and saturated barium hydroxide. Mixtures were
centrifuged at 14000 x gfor 20 min and filtered through 0.45 ^im filters (MSI,
Westboro, MA). The filtrate (300 pJ) and 7 pJ of NNK metabolite standards were
injected onto a reversed-phase HPLC system using a pBondapak C18 column
(3.9 x 300 mm, Waters, Milford, MA). NNK and its metabolites were eluted with
sodium acetate buffer (pH 6) and methanol [25]. Keto aldehyde-bisulfite adducts
were stabilized by addition of 1 mM sodium bisulfite to the elution buffer. The
eluate was collected in one ml fractions and combined with scintillation cocktail.
The radioactivity in the fractions was determined by liquid scintillation
spectroscopy (Beckman LS5801 counter, Beckman Instrument Division,
Berkeley, CA). Metabolic activity was expressed as pmol/mg microsomal protein
per min.
2.4 Statistical analysis
Data were analyzed by the Student’s unpaired t-test using the Macintosh
Stat-View software program. Statistical significance was defined as p < 0.05
compared with control values.
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Fig. 1. Metabolic pathways of NNK, i.e. carbonyl reduction (pathway a),
pyridine N-oxidation (pathway b) and a-carbon hydroxylation (pathway
c). Modified from Hecht et al. [13].
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3. RESULTS AND DISCUSSION
The pathways in the microsomal metabolism of NNK are shown in Figure
1. Carbonyl reduction of NNK yields the N-nitroso alcohol NNAL (pathway a). Noxidation of the pyridine ring of NNK and NNAL yields NNK-N-oxide and NNALN-oxide, respectively (pathway b). Keto alcohol is a product of methyl
hydroxylation and keto aldehyde comes from a-methylene hydroxylation
(pathway c). The inclusion of sodium bisulfite in the incubation mixture and in
the HPLC eluant forms and stabilizes the keto aldehyde-bisulfite adduct [25].
Subsequent oxidation/reduction of keto alcohol and keto aldehyde yield keto
acid, hydroxy acid and diol.
The effects of pycnogenol on the metabolism of NNK by liver microsomes
of 6 mo and 20 mo F344 male rats are shown in Figure 2. Carbonyl reduction of
NNK was inhibited by pycnogenol in a concentration-dependent manner in both
6 mo and 20 mo liver microsomes. This pathway was the major pathway of NNK
metabolism in rat liver microsomes. N-oxidation and a-hydroxylation (pathway b
and c, respectively) of NNK represented minor metabolic pathways in these
microsomes. Pycnogenol inhibited a-hydroxylation (pathway c) but did not
significantly inhibit N-oxidation (pathway b). A concentration-dependent
inhibition of NNK metabolism by pycnogenol was also indicated by the amounts
of unmetabolized NNK compared to control samples without pycnogenol.
Figure 3 shows the effects of pycnogenol on the metabolism of NNK by
lung microsomes of 6 mo and 20 mo F344 male rats. The major metabolic
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pathway in lung microsomes of both age groups was a-hydroxylation (pathway c)
in contrast to carbonyl reduction in liver microsomes (Figure 2). Pycnogenol
gave a concentration-dependent inhibition of all pathways of NNK metabolism in
rat lung microsomes.
Other phytochemicals have been shown to modulate the metabolic
activation and carcinogenic potential of NNK in both in vitro and in vivo studies.
Most of these phytochemicals are present in food and drink common to human
use. They include isothiocyanates [4,7,21], d-limonene [22,28], indoles [4],
diallyl sulfide [16], (+)-catechin [17] and green and black tea phenols [27,29]. To
our knowledge this is the first report of the inhibition of microsomal-dependent
metabolism of NNK by pycnogenol.
Data shown in Figures 2 and 3 suggest that there was a small decrease in
microsomal activity in both liver and lung in the 20 mo rats compared to
microsomal activity in the 6 mo old rats. Other investigators have observed
similar age-related differences. Cytochrome P450-dependent enzyme activities
but not phase II drug-metabolizing enzymes were shown to diminish between 6
mo and 24 mo in the white-footed mouse [10]. A significant decrease in rat
hepatic mutagenic activation of aflatoxin B1 and 2-aminoanthracene but not
benzo[a]pyrene was observed with increasing age of the rat [14]. Our study
showed that the concentration-dependent inhibition of a-hydroxylation by
pycnogenol occurred in lung microsomes from both 6 mo and 20 mo rats.
We investigated pycnogenol because it is widely marketed in health food
establishments in Europe and in the United States and because there are few
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published scientific studies describing its health-promoting efficacies. The
results of our study suggest that pycnogenol may afford some protection against
the mutagenic and carcinogenic effects of NNK as indicated by the
concentration-dependent inhibition of a-hydroxylation (pathway c, Figure 1) in rat
lung microsomes. This pathway generates the reactive products that methylate
and pyridyloxobutylate DNA [13]. Our findings complement the reported freeradical scavenging action of pycnogenol [26] and support a chemopreventive
action toward NNK-induced lung tumorigenesis.
Additional in vitro and in vivo studies are necessary to obtain a clearer
understanding of the actions of pycnogenol and to determine whether it
possesses health promoting properties.
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ABSTRACT
NNK is a tobacco-specific nitrosamine that requires metabolic activation
by cytochrome P450 enzymes. NNK may be metabolized via carbonyl reduction,
N-oxidation, and a-carbon hydroxylation. Pycnogenol is a mixture of flavonoid
compounds extracted from pine tree bark and is available as a dietary
supplement. We have previously shown that pycnogenol inhibits the in vitro
metabolism of NNK in lung and liver microsomes of F344 rats in a concentrationdependent manner. In this report, intragastrically administered pycnogenol in
saline affected NNK metabolism in lung microsomes differently than in liver
microsomes of F344 rats. The administered pycnogenol was inhibitory toward
NNK activation in lung microsomes but not in liver microsomes suggesting that
pycnogenol may afford chemoprotection toward NNK-induced lung tumorigenesis
when administered orally but not toward NNK-induced liver tumorigenesis. The
effects of intragastrically administered pycnogenol on NNK metabolism in lung
and liver microsomes were similar in 6 mo and 20 mo old rats although the level
of NNK metabolism was less in the 20 mo old animals.
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INTRODUCTION
Lung cancer is the leading cause of death in both men and women in the
United States. The American Cancer Society estimates that lung cancer
accounted for 28% of all cancer deaths in 1998. The etiological factors most
likely to cause lung cancer are tobacco-specific nitrosamines present in tobacco
smoke. The most abundant tobacco-specific nitrosamines are N1nitrosonornicotine (NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
and its major metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
(1). NNK is bioactivated by cytochrome P450 enzymes to form alkylating
intermediates (2-5). The major metabolic pathways of NNK metabolism (Figure
1) are carbonyl reduction (pathway a), N-oxidation (pathway b), and a-carbon
hydroxylation (pathway c). N-oxidation of NNK is a deactivation pathway
whereas a-hydroxylation is an activation pathway (6). a-Hydroxylation of NNK
results in hemoglobin and DNA adducts (7). NNK is metabolized in various
organs including lung, liver, nasal mucosa, and the oral cavity (8, 9). The
metabolism of NNK by these organs may put smokers at risk for developing
secondary organ damage.
There is a growing interest in the properties of plant-derived compounds
(phytochemicals) and their effectiveness as chemoprotective agents.
Chemoprotective agents include naturally occurring chemicals like certain
vitamins, isoflavonoids, polyphenols, genistein and isothiocyanates (10).
Chemoprotective compounds exert their effects by inhibiting the formation of
carcinogens, by inhibiting some enzymes while inducing others, by acting as
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free-radical scavengers and/or by suppressing specific biological actions (10,
11). Pycnogenol is a mixture of flavonoid compounds extracted from pine tree
bark (12). The mixture of flavonoids in pycnogenol acts as a strong antioxidant
and free-radical scavenger (12, 13). The contribution of free radicals to
processes of tissue injury and aging are reported (14-16). Microsome fractions
contain cytochrome P450 enzymes that metabolize xenobiotics including
carcinogens, mutagens and therapeutic agents (17). The effects of flavonoids on
microsomal enzymes have been described (18, 19). We have reported
previously that pycnogenol inhibits the in vitro O-dealkylation of alkoxyresorufins
indicating the inhibition of cytochrome P450 isoforms 1A2, 2C6, and 2B in rat
liver and lung microsomes (20) and inhibits the in vitro metabolism of NNK (21).
We report here the effects of intragastrically administered pycnogenol on NNK
metabolism in lung and liver microsomes of F344 rats at 6 mo and 20 mo of age.

MATERIALS AND METHODS
Chemicals
NADP+, glucose-6-phosphate and glucose-6-phosphate dehydrogenase
were purchased from Sigma Chemical Co. (St. Louis, MO). [5-3H] NNK (2.51
Ci/mmol) was obtained from Chemsyn Science (Lenexa, KS). NNK metabolites
used as reference standards were prepared as described (22).
Animals
Male F344 rats age 6 mo and 20 mo were purchased from Harland
Laboratory, Inc (Indianapolis, IN). The rats were housed under light- and
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temperature-controlled conditions and were provided water and rodent laboratory
chow ad libitum.
Preparation of microsomes
Following acclimatization, the rats were administered 5 mg pycnogenol/kg
body weight in saline intragastrically once each day for three consecutive days.
Twelve hr after the last intragastric dose, the animals were asphyxiated under
C02 gas and the livers and lungs were removed and transferred to ice-cold 0.1 M
Tris-HCI buffer (pH 7.4). The organs were minced and homogenized and
microsomes were prepared by differential centrifugation (23). Cytosol and
microsome protein contents were determined (24). One-ml aliquots of the
cytosol and microsomal fractions were stored at -80° C prior to use in the NNK
assay.
Assays of NNK Metabolism
The effects of pycnogenol on the metabolism of NNK by liver and lung
microsomes from 6 mo and 20 mo F344 rats were studied using a modification of
a previously described procedure (22). Incubation mixtures contained 5 mM
glucose-6-phosphate, 1.5 units glucose-6-phosphate dehydrogenase, 1 mM
NADP+, 1 mM EDTA, 3 mM MgCI2) 3 pCi [5-3H] NNK, and 5 mM sodium bisulfite
in a final volume of one ml. Following incubation at 37° C for 10 min, the reaction
was started by adding 0.5 mg of liver or lung microsomal protein. The mixtures
were incubated for 30 min in triplicate in a shaking waterbath at 37° C.
Reactions were stopped by the addition of 200 pi each of 25% zinc sulfate and
saturated barium hydroxide. Mixtures were centrifuged at 14000 x G for 20 min
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and filtered through 0.45 |nm filters (MSI, Westboro, MA). NNK and its
metabolites were eluted with sodium acetate buffer (pH 6) and methanol (22).
Keto aldehyde-bisulfite adducts were stabilized by addition of 1 mM sodium
bisulfite to the elution buffer. The eluate was collected in one ml fractions and
combined with scintillation cocktail. Radioactivity in the fractions was determined
by liquid scintillation spectroscopy (Beckman LS5801 counter, Beckman
Instrument Division, Berkeley, CA). Metabolic activity was expressed as
pmol/mg microsomal protein/min.
Statistical Analysis
Experiments were performed in triplicate using lung and liver microsomal
protein from each of six rats in each age group. Values are the mean ± SEM
from all experiments and are expressed in pmol/mg protein/min. Data were
analyzed by the Student's paired two-tailed t-test. Statistical significance was
defined as p < 0.05 compared to control values (no pycnogenol).

RESULTS
The amount of unmetabolized NNK recovered from liver microsomes of 6
mo and 20 mo rats was greater in rats administered pycnogenol than in
untreated groups (Figure 2). This suggests a small but statistically significant
overall inhibition of NNK metabolism. The major pathway of NNK metabolism in
liver microsomes of both 6 mo and 20 mo old rats was carbonyl reduction to
NNAL. Carbonyl reduction and N-oxidation of NNK was significantly inhibited in
pycnogenol-treated rats compared to the untreated control animals.
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a-Hydroxylation was slightly enhanced by the administration of pycnogenol in
liver microsomes of both 6 mo and 20 mo rats. The 20 mo old rats exhibited less
metabolic activity compared to the 6 mo old rats.
In contrast to liver microsomes, lung microsomes exhibited more Noxidation and a-hydroxylation of NNK (Figure 3). N-oxidation in lung microsomes
was enhanced by treatment with pycnogenol whereas NNK reduction was
inhibited. a-Hydroxylation of NNK was inhibited in lung microsomes of 20 mo old
F344 rats but not of 6 mo old rats. Overall metabolism of NNK was enhanced in
lung microsomes of 6 mo old animals but not of 20 mo old animals. Age
differences in response to intragastric administration of pycnogenol were more
evident in lung microsomal metabolism of NNK than in liver microsomal
metabolism of NNK.

DISCUSSION
Phytochemicals including certain dietary ones are reported to modulate
chemical carcinogenesis. Among these plant products are flavonoids and their
glycosides that are widely distributed in fruits, vegetables and nuts (25). Studies
of the effects of phytochemicals on NNK metabolism include catechins, found in
green tea; isothiocyanates, found in cruciferous vegetables; diallyl sulfide, found
in garlic; limonene, found in citrus fruits; and capsaicin, found in chili peppers. It
is reported that when given as the sole source of drinking fluid, green tea inhibits
NNK-induced DNA methylation in the lungs of female A/J mice, thus reducing the
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occurrence of point mutation and activation of cellular protooncogenes (9, 11). In
another study, Chung et al have demonstrated strong inhibition of NNK-induced
DNA methylation by isothiocyanates given to F344 rats either 2 hours or 2 weeks
prior to sacrifice (26). Simultaneous treatment with phenethyl isothiocyanate
(PEITC) and NNK results in selective inhibition of NNK activation in rat lung but
not liver (27). Diallyl sulfide, limonene, and capsaicin have also been shown to
significantly reduce NNK metabolism in rats and mice (28-30). These studies
and others contribute to our current understanding of the potential protection
afforded by flavonoids towards NNK-induced tumorigenesis.
Pycnogenol, an extract from pine trees, has been reported to contain
flavonoids and proanthocyanidins (13). It is available in Europe and the United
States for human consumption based on its antioxidant effects (12, 31-33).
Although there are scientific reports describing the effects of pycnogenol on freeradical scavenging, to our knowledge there are no reports of the effects of orallyadministered pycnogenol on the metabolism of the tobacco-specific nitrosamine
NNK. We have previously reported that pycnogenol inhibits the in vitro
metabolism of NNK in a concentration-dependent manner when it is included in
the incubation mix containing lung and liver microsomes of F344 rats. The
nicotine-derived N-nitrosamine NNK is present in tobacco smoke and induces
lung tumors in animal models (8) and is a probable causative factor in the
induction of lung carcinogenesis in human smokers (7). The metabolic pathways
mediated by microsomal cytochrome P450 enzymes are shown in Figure 1. ocCarbon hydroxylation (pathway c) is an activation pathway. N-oxidation
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(pathway b) is a deactivation pathway (34). The NNK metabolite NNAL (pathway
a) can be conjugated to glucuronic acid or activated by the a-hydroxylation
pathway (9). Results from our current study show a small but statistically
significant decrease in the overall metabolism of NNK in liver microsomes of 6
mo and 20 mo F344 rats following the intragastric administration of pycnogenol
as described in Materials and Methods. The effects of NNK reduction, Noxidation, and a-hydroxylation of NNK, however, indicate that the administered
pycnogenol may enhance the activation of NNK in liver microsomes (Figure 2).
The significance of the reduction of NNK to NNAL depends upon whether the
NNAL is conjugated to glucuronic acid. Unpublished data from our laboratory
indicates that intragastrically administered pycnogenol has no effect on
glutathione-S-transferase activity.
The effects of administered pycnogenol on the metabolism of NNK in lung
microsomes of 6 mo and 20 mo old F344 rats showed a different pattern from
that of NNK metabolism in liver microsomes (Figure 3). The data suggest that
the pycnogenol may afford more protection toward lung tumorigenesis than
toward liver tumorigenesis induced by NNK. The data also indicate that the
reduction of NNK to NNAL is a less significant pathway in rat lung than in rat
liver. Inhibition of a-carbon hydroxylation was not statistically significant in lung
microsomes of the 6 mo old animals, which suggests an age-related difference in
the effects of the administered pycnogenol. The differences in the metabolism of
NNK in rat lung compared to rat liver suggest that the administered pycnogenol
may have organ specific effects. The effects of intragastrically administered
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pycnogenol on NNK metabolism in lung and liver microsomes of F344 rats differ
from those obtained in the strictly in vitro studies where there was a
concentration-dependent inhibition of all three NNK metabolism pathways (i.e.
NNK reduction, N-oxidation and a-hydroxylation) in lung and liver microsomes of
both 6 mo and 20 mo old rats (21).
In summary, data presented in this report suggest that ingested
pycnogenol may afford protection toward NNK-induced lung tumorigenesis but
not toward NNK-induced liver tumorigenesis. Additional studies will be
necessary to clarify whether pycnogenol actually affords any efficacious
protection toward NNK-induced tumorigenesis, particularly in human smokers.
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SUMMARY
Cytochrome P450 enzymes catalyze the metabolism of most carcinogens
and drugs. Plant compounds have been shown to be effective modulators of the
P450 enzymes. Pycnogenol is a mixture of procyanidins found in the bark of
pine trees. We utilized four different concentrations of pycnogenol to study its
effect on the deakylation of methoxyresorufin (MROD), ethoxyresorufin (EROD)
and benzyloxyresorufin (BROD), the substrates for CYP1A2, 2C6 and 2B,
respectively. Pycnogenol at all tested concentrations inhibited MROD and
EROD activities of liver microsomes from 6 mo and 20 mo male F344 rats.
Pycnogenol inhibited BROD activity of 6 mo liver microsomes but had no
statistically significant effect on BROD activity of 20 mo liver microsomes.
MROD and EROD activities were enhanced by pycnogenol in lung microsomes
from 6 mo and 20 mo male F344 rats. Pycnogenol at all tested concentrations
inhibited BROD activity of lung microsomes from 6 mo and 20 mo animals. Our
results suggest that pycnogenol may exhibit selective inhibition of cytochrome
P450 isoenzymes in the lung and liver.
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INTRODUCTION
Chemoprevention is an important defensive mechanism for protection
against chronic diseases including cancer and cardiovascular diseases.
Chemopreventive agents include naturally occurring compounds such as some
vitamins, plant polyphenols, flavonoids, diallyl sulfides (found in garlic) and
genistein (found in soybean) (Stavric 1994). Chemopreventive agents have
several mechanisms of action including inhibition of carcinogen formation,
inhibiting certain enzymes while inducing others, acting as free radical
scavengers, and suppressing certain biologic functions (Stavric 1994).
Pycnogenol is a mixture of oligomeric and monomeric procyanidins
extracted from the bark of maritime pine trees (Pinus maritima) (Rong et al
1994). The mixture of flavonoids in pycnogenol contributes to its action as a
strong antioxidant (Rong et al 1994) and free radical scavenger (Passwater and
Kandaswami 1994). Detailed reviews of the involvement of free radicals in aging
and tissue injury have been reported (Poli 1993, Nohl 1993, Ward 1994). In
biological systems, free radicals are generated during oxidative metabolism of
parent compounds into chemically reactive intermediates which can cause cell
injury and cell death (Slater and Cheeseman 1988). Cytochrome P450 enzymes
are mixed function oxidases found in the microsomal fraction of liver and lung
tissues. P450 enzymes are responsible for much of the metabolic activation of
carcinogens, xenobiotics and therapeutic agents (Estabrook 1996). The effects
of natural flavonoids on monooxygenase activities have been previously reported
(Canivenc-Lavier et al 1996, Siess et al 1995). Methoxyresorufin,
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ethoxyresorufin, and 7-benzyloxyresorufin are substrates selectively dealkylated
by CYP1A2, 2C6, and 2B, respectively (Burke et al 1994, Verschoyle et al 1993).
To further characterize pycnogenol, we studied the effect of pycnogenol on the
O-dealkylation of methoxyresorufin, ethoxyresorufin, and 7-benzyloxyresorufin.

MATERIALS AND METHODS
Chemicals
Pycnogenol was a gift from Dr. B. Lau (Dept, of Microbiology, Loma Linda
Univ.). Methoxyresorufin was purchased from Molecular Probes (Eugene, OR).
Ethoxyresorufin, 7-benzyloxyresorufin, resorufin, NADPH and other reagents of
the highest purity were purchased from Sigma Chemical Co. (St. Louis, MO).
Preparation of microsomes
After sacrificing, the livers and lungs from 6 mo old (350-395 grams) and
20 mo old (410-490 grams) male F344 rats were removed and washed in 0.05 M
Tris-HCI buffer (pH 7.5) at 25° C. After weighing, two volumes of Tris-HCI buffer
were added. The livers and lungs were minced and homogenized and
microsomes were prepared by differential centrifugation (Maron and Ames
1983). Protein concentrations were determined by the method established by
Lowry et al (1951).
Assay for Cytochrome P450 activity
O-dealkylation of methoxyresorufin (MROD), ethoxyresorufin (EROD), and
7-benzyloxyresorufin (BROD) were used to measure the in vitro effect of
pycnogenol on cytochrome P450 activity. Methoxyresorufin is dealkylated by
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CYP1A2, ethoxyresorufin is dealkylated by CYP2C6 while 7-benzyloxyresorufin
is dealkylated by CYP2B (Burke et al 1994, Verschoyle et al 1993). The assays
to determine the O-dealkylation of these three alkoxyresorufins were adapted
from the method of Lubet et al (1985). Reaction tubes contained 0.5 nmole of
substrate in 0.05 M Tris-HCI buffer (pH 7.4), 0.5 mg microsomal protein and
varying concentrations of pycnogenol (0 jug, 20 pg, 40 pg, 80 ng, and 120 jig) in
a final volume of one ml. Each reaction was initiated by addition of 2.5 nM
NADPH, incubated for 10 min. in a shaking water bath at 37° C and then stopped
by addition of 2-ml methanol. The mixtures were then centrifuged at 2000 RPM
for 5 min. Fluorescence of the supernatant was determined in a Perkin-Elmer
fluorescence spectrophotometer (Model MPF-3L, ^ex = 522 nm, X em = 586 nm).
Statistical Analysis
Each experiment was performed using pooled microsomes from 2
animals. Data are given as the mean ± SEM of 3-13 separate experiments and
were analyzed by paired two-tailed Student’s t-test. Values are expressed as
nmol resorufin/mg protein/min. Statistical significance was defined as P < 0.05
compared to control values (no pycnogenol).

RESULTS
The in vitro effect of pycnogenol on MROD, EROD, and BROD activity of
liver microsomes from 6 mo male F344 rats is shown in Figure 1A. Both MROD
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Figure 1. The effect of different concentrations of pycnogenol on the in
vitro activity of MROD, EROD, and BROD in liver microsomes from 6
mo (A) and 20 mo (B) male F344 rats. Data is reported as the mean ±
SEM of 6-8 separate experiments. Each experiment used microsomes
pooled from 2 animals. Procedural details for performing the
experiments are given in Materials and Methods. Asterisks indicate
statistical significance, defined as P < 0.05 compared to control values.
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(CYP1A2) and BROD (CYP2B) activities were significantly reduced by
pycnogenol at all concentrations tested. EROD (CYP2C6) activity was
effectively reduced at all concentrations of pycnogenol, except the 20 |ig/ml
concentration.
The in vitro effect of pycnogenol on the MROD, EROD, and BROD activity
of liver microsomes from 20 mo male F344 rats is shown in Figure 1B. MROD
and EROD activities were significantly reduced by pycnogenol at all
concentrations tested. Pycnogenol had no statistically significant effect on
BROD activity.
The in vitro MROD and EROD activity of lung microsomes from 6 mo
male F344 rats in the presence of pycnogenol is shown in Figure 2A. Both
MROD and EROD activity was significantly increased by pycnogenol.
Pycnogenol at all concentrations tested had a small inhibitory effect on BROD
activity.
Figure 2B shows the in vitro effect of pycnogenol on MROD, EROD, and
BROD activity of lung microsomes from 20 mo male F344 rats. In a similar
pattern as the 6 mo lungs, MROD activity was effectively enhanced at all
concentrations of pycnogenol, except the 20 jag/ml concentration. EROD activity
was increased while BROD activity was significantly reduced by pycnogenol at all
concentrations tested.

80

A
20

6 mo Lung

□ Ong/ml
E320 ^g/ml

18

□ 40 (ig/ml

-£
16
c
E

14

1

12

s

;r

i

i

□ 80 ^g/ml
11120 fig/ml

■

a

§. 10 -

■I!

8-

E
c

i

ii

!

S|| |

O)

I

i

n

6 -

I
II

4 2 -

!
||§§

.11
;. .

IS

0

MROD

EROD

BROD

B
20

20 mo Lung

□ 0 ng/ml
□ 20 ng/ml

18

□ 40 ng/ml

*

□ 80 ^g/ml

16

I f

□ 120 ng/ml
14

1M

1 >2

Utah

It

.E
2
2

Q.

■

10

c

8

4
2 0

i

Ifi
11

1

§

IS
1

ii

S5^

Hi!

6

i

i

s::s!

O)

E
o
E

1

li

!

MROD

EROD

«

i

iII

BROD

Figure 2. The effect of different concentrations of pycnogenol on the in
vitro activity of MROD, EROD, and BROD in lung microsomes from 6
mo (A) and 20 mo (B) male F344 rats. Data is reported as the mean ±
SEM of 6-8 separate experiments. Each experiment used microsomes
pooled from 2 animals. Procedural details for performing the
experiments are given in Materials and Methods. Asterisks indicate
statistical significance, defined as P < 0.05 compared to control values.
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DISCUSSION
Flavonoids are found in fruits, vegetables, tea, seeds, bark, nuts, and
flowers (Obermeier et al 1995). Pycnogenol is a mixture of compounds including
procyanidins, flavonoids, and organic acids (Passwater and Kandaswami 1994).
It is premature to conclude that the effects presented in this study may be
attributed to any one component in pycnogenol because of its mixed
composition. The effects of pycnogenol on the metabolic activities of
cytochrome P450 presented here correlate positively with findings by earlier
investigators who reported the protective effects of phytochemicals against some
environmental and dietary mutagens and carcinogens (Bu-Abbas et al 1994, Cai
et al 1993, Canivenc-Lavier et al 1996, Obermeier et al 1995, Siess et al 1995,
and Surh et al 1995). Capsaicin, the pungent compound in chili peppers, was
found to inhibit bacterial mutagenicity as well as hydroxylation and demethylation
reactions mediated by CYP2E1 (Zhang et al 1997), the isoenzyme involved in
the metabolism of ethanol. Capsaicin inhibited the demethylation of MROD,
indicating that capsaicin can modulate the metabolic activity of CYP1A2 (Teel et
al 1997). Green tea was shown to enhance O-dealkylation of methoxyresorufin,
ethoxyresorufin and pentoxyresorufin (Bu-Abbas et al 1994). Fifteen different
coumarins found in the human diet were effective as potent inhibitors of EROD
and PROD activity in vitro (Cai et al 1993). Flavonoids inhibited resorufin Odealkylation (Canivenc-Lavier et al 1996, Obermeier et al 1995, and Siess et al
1995), further indicating that phytochemicals can and do alter biological enzyme
functions.
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In this study, the in vitro activity of MROD and EROD in liver microsomes
from 6 mo and 20 mo F344 male rats were dose-dependently inhibited by
pycnogenol. At the 120 jiig/ml concentration of pycnogenol, MROD activity in
liver microsomes was reduced by 46% in 6 mo and 53% 20 mo rats. The
reduction of EROD activity by 120 pg/ml concentration of pycnogenol was 49%
in microsomes from 6 mo rats and 54% in microsomes from 20 mo rats. The
activity of BROD in 6 mo liver microsomes was reduced by 42% of control
however BROD activity in 20 mo liver microsomes was not significantly different
from control in the presence of pycnogenol.
Pycnogenol at all investigated concentrations enhanced in vitro MROD
and EROD activity in lung microsomes from 6 mo and 20 mo F344 male rats.
The 120 pg/ml concentration of pycnogenol enhanced MROD activity in 6 mo
lung microsomes by 52% and by 54% in 20 mo lung microsomes. The activity of
EROD was enhanced by 90% in 6 mo animals and by 114% in 20 mo animal at
the 120 pg/ml concentration. BROD activity in lung microsomes from 6 mo and
20 mo rats was significantly reduced by 120 jug/ml pycnogenol (24% and 25%
respectively).
Except for the difference in MROD activity observed between the 6 mo
and 20 mo liver microsomes of F344 rats, there was no statistically significant
difference in EROD and BROD activities between the two age groups. It is
reported that cytochrome P450-dependent reactions decreased with age in mice
and rats (Guo et al 1993 and Hilali et al 1993). Our data show an age-related
difference in the effect of pycnogenol on BROD activity between microsomes
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from 6 mo rats and those of 20 mo rats but not in MROD and EROD activities in
the two age groups. The most unique observation in our studies was the
stimulating effect of pycnogenol on MROD and EROD activity in lung
microsomes of the F344 rats. The effect was seen irrespective of the age of the
animals. The significance of this reversed effect of pycnogenol compared to
MROD and EROD activity in liver microsomes remains to be determined through
additional studies.
In conclusion, our study shows that pycnogenol affected the activity of
isoforms of cytochrome P450 in a somewhat selective manner. It inhibited CYP
1A2 and 2C6 activities in liver microsomes from both 6 mo and 20 mo F344 rats
but had no effect on CYP 2B activity in liver microsomes from 20 mo rats. In
contrast to the inhibiting effects of pycnogenol on CYP 2B activity in lung
microsomes from both 6 mo and 20 mo animals, it enhanced the activity of CYP
1A2 and 2C6 in these microsomes. Pycnogenol is widely marketed in both the
United States and Europe, however there are few published scientific studies
describing its efficacies. Our results suggest more of an organ response
sensitivity than an age-related sensitivity of microsomes to pycnogenol. In
addition, our data suggest that pycnogenol may have some selective effects on
isoforms of cytochrome P450. Expanded in vitro and in vivo studies are needed
to further clarify our understanding of the actions of pycnogenol and to determine
whether it possesses health promoting properties.
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SUMMARY
Pycnogenol® is a combination of flavonoids and other phenolic
compounds extracted from pine bark. In the present study, we investigated the
effect of Pycnogenol® administered intragastrically on Phase I and Phase II
enzyme activities in liver and lung from 6 mo and 20 mo male F344 rats.
Cytochrome P450-linked O-dealkylation of benzyloxyresorufin (BROD),
ethoxyresorufin (EROD) and methoxyresorufin (MROD) was inhibited in liver
microsomes from 6 mo and 20 mo rats administered Pycnogenol®. MROD
activity in lung microsomes from Pycnogenol®-treated animals was also inhibited
whereas EROD activity was increased in lung microsomes. Glutathione-Stransferase (GST) activity, a marker of Phase II enzyme activity, was not
significantly affected by Pycnogenol® treatment in either liver or lung from these
animals. Our results suggest that intragastrically administered Pycnogenol® may
affect the activity of isoforms of cytochrome P450 and therefore affect the
metabolism of substrates for these isoforms but may not affect detoxification
mediated by GST.
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INTRODUCTION
Pycnogenol® is a complex mixture of phenolic compounds extracted from
the bark of the French maritime pine (Pinus maritima). Recent studies have
identified some of the components of Pycnogenol®. Pycnogenol® contains
procyanidins, which are a class of nonhydrolyzable tannins and are composed of
units of catechin or epicatechin linked together by 4-8 or 4-6 bonds (Rohdewald
1998). Pine bark extract also contains phenolic acids in the form of free acids (phydroxybenzoic, gallic, vanillic, caffeic, and ferulic acid) and glucosides and
glucose esters (Rohdewald, 1998). Previous investigators have shown that
Pycnogenol® inhibits lipid peroxidation, and scavenges superoxide, hydroxyl and
trichloromethylperoxide radicals (Rohdewald, 1998). Constituents of pine bark
extract block the metabolism of arachidonic acid by inhibiting 5-lipoxygenase and
the formation of leukotrienes but not cycloxygenase and inflammation
(Rohdewald, 1998).
Cytochrome P450 is a family of enzymes found in the microsomal
fractions of the endoplasmic reticulum and the mitochondria of animal tissues
(Guengerich, 1993). The P450 enzymes are responsible for the metabolism of
endogenous and exogenous compounds, including steroids, fatty acids,
eicosanoids, carcinogens and pharmaceutical drugs (Estabrook, 1996;
Guengerich, 1993). It is well documented that plant-derived compounds can
modulate enzyme activities. Flavonoids inhibit P450-mediated dealkylation of
ethoxyresorufin and pentoxyresorufin (Obermeier et al, 1995). The plant
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derivative chlorophyllin inhibits several P450-dependent enzymes including those
associated with EROD and BROD activity (Yun et al, 1995).
Glutathione-S-transferase (GST) is a detoxification enzyme that catalyzes
the conjugation of reduced glutathione (GSH) and cytotoxic electrophilic
compounds and acts as cellular defense against oxidative stress (Krengel et al,
1998; Ketterer and Christodoulides, 1994; Carlberg and Mannervik, 1975). GSTs
are found in both microsomal and cytosolic fractions of tissues, with the liver
having the highest concentration. Molecular studies have identified four groups
within the GST supergene family of enzyme (Ketterer and Christodoulides,
1994). GSTs are dimers and each subunit has two domains. The active site of
the enzyme lies between the domains (Ketterer and Christodoulides, 1994).
Antioxidants of plant origin including rosemary extracts, flavone, flavanone, and
tangeretin decrease cytochrome P450 activity and increase GST activity
(Canivenc-Lavier et al, 1996; Offord et al, 1995). Activities of rat hepatic GST
isozymes markedly increase when rats are fed ellagic acid and beta-carotene
(Ahn et al, 1996; Astorg et al, 1994). In our studies of the pharmacologic
properties of Pycnogenol®, we report here the in vivo effects of intragastric
administration of Pycnogenol® on the activity of cytochrome P450 isoenzymes
associated with the O-dealkylation of alkoxyresorufins and on glutathione-Stransferase activity.
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MATERIALS AND METHODS
Chemicals
Pycnogenol® was a gift from Dr. B. Lau (Dept, of Microbiology, Loma
Linda Univ.). Methoxyresorufin was purchased from Molecular Probes (Eugene,
OR). 1-Chloro-2, 4-dinitrobenzene was purchased from Aldrich Chemical Co.
(Milwaukee, Wl). Reduced glutathione, ethoxyresorufin, benzyloxyresorufin
resorufin, NADPH, and other reagents of the highest purity were purchased from
Sigma Chemical Co. (St. Louis, MO).
Animals
Male F344 rats age 6 mo and 20 mo were purchased from Harland
Laboratory, Inc (Indianapolis, IN). The rats were housed under light- and
temperature-controlled conditions and were provided water and rodent laboratory
chow ad libitum.
Preparation of microsomes
Following acclimatization, the rats were administered 5 mg pycnogenol/kg
body weight in saline intragastrically once each day for three consecutive days.
Twelve hr after the last intragastric dose, the animals were asphyxiated under
C02 gas and the livers and lungs were removed and transferred to ice-cold 0.1 M
Tris-HCI buffer (pH 7.4). The organs were minced and homogenized and
microsomes were prepared by differential centrifugation (Maron and Ames
1983). Cytosol and microsome protein contents were determined (Lowry et al,
1951). One-ml aliquots of the cytosol and microsomal fractions were stored at 80°C prior to use in the enzyme assays.
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Assay for Cytochrome P450 enzyme activity
O-dealkylation of methoxyresorufin, ethoxyresorufin, and
benzyloxyresorufin was determined by the method of Lubet et al (1985).
Reaction mixtures contained 0.5 jamole of MR, ER, or BR, 0.5 mg liver or lung
microsomal protein from Pycnogenol®-treated and control F344 rats in a final
volume of one ml 0.05 M Tris-HCI buffer (pH 7.4). The reactions were initiated
by the addition of 2.5

NADPH and incubated for 10 min in a shaking water

bath at 37°C. Two ml of methanol were added to stop the reactions. The
mixtures were centrifuged at 2000 rpm for 5 min and the fluorescence of the
supernatant was determined using a Perkin-Elmer fluorescence spectrometer
(Model MPF-3L, Xex=522 nm, ^em=586 nm). Enzyme activity was expressed in
nmol/mg microsomal protein/min.
Assay for GST activity
The reactions were conducted in a two-sided cuvette containing a final
volume of one ml. Each reaction mixture contained 1 mM EDTA, one jumole
reduced glutathione, one nmole 1-chloro-2, 4-dinitrobenzene and 0.1 mg
cytosolic protein in 0.1 M sodium phosphate buffer (pH 6.5) (Warholm et al
1985). The increase in absorbency at 340 nm was measured using a UV-VIS
spectrometer (Spectronic Instruments Inc., Rochester, NY). Spontaneous GST
activity was corrected for by subtracting the rate of absorbency in the absence of
enzyme. GST activity was expressed in nmol/mg cytosol protein/min.
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Statistical Analysis
Experiments were performed in triplicate using microsomal or cytosolic
protein from 6 individual rats in each age group. Values expressed in nmol/mg
protein/min are the mean ± SEM from all experiments and were analyzed by the
Student's paired two-tailed t-test. Statistical significance was defined as p < 0.05
compared to control values (no Pycnogenol®).

RESULTS
The in vivo effects of intragastrically administered Pycnogenol® on the Odealkylation of benzyloxyresorufin (BROD), ethoxyresorufin (EROD) and
methoxyresorufin (MROD) by liver microsomes from 6 mo and 20 mo male F344
rats are shown in Figure 1. BROD and MROD activity in 6 mo animals was
significantly inhibited by Pycnogenol® administration, whereas EROD activity was
not significantly different statistically from EROD activity in control rats (Figure
1A). Pycnogenol® administration effectively reduced the activity of BROD,
EROD, and MROD in microsomes from 20 mo animals (Figure 1B).
BROD, EROD, and MROD activity in lung microsomes from 6 mo and 20
mo male F344 rats treated with Pycnogenol® is shown in Figure 2. MROD
activity in lung microsomes from both age groups was significantly inhibited by
treatment with Pycnogenol® whereas EROD activity was increased compared to
the untreated controls. BROD activity was not significantly different statistically
from control animals.
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Figure 1 The effect of Pycnogenol® administered intragastrically
on BROD, EROD, MROD activity in liver microsomes from 6 mo
(A) and 20 mo (B) F344 male rats. Data are the mean ± SEM
from 6 individual rats in each age group. Procedural details are
described in Materials and methods. Asterisks indicate statistical
significance defined as p < 0.05 compared to control values.
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Figure 2 The effect of Pycnogenol® administered intragastrically
on BROD, EROD, MROD activity in lung microsomes from 6 mo
(A) and 20 mo (B) F344 male rats. Data are the mean ± SEM
from 6 individual rats in each age group. Procedural details are
described in Materials and methods. Asterisks indicate statistical
significance defined as p < 0.05 compared to control values.
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The effect of Pycnogenol® administration on glutathione-S-transferase
activity in liver and lung cytosolic fractions from 6 mo and 20 mo male F344 rats
is shown in Figure 3. Glutathione-S-transferase activity in treated animals was
not significantly different statistically from controls.

DISCUSSION
Pycnogenol® is a mixture of some 30 compounds including procyanidins,
flavonoids and organic acids (Passwater and Kandaswami, 1994). We have
previously shown a concentration-dependent inhibition of MROD and EROD
activity in F344 rat liver microsomes and an increase in EROD and MROD
activity in F344 rat lung microsomes in in vitro incubations that included
Pycnogenol® (Huynh and Teel, 1998). In the current study, F344 male rats
administered Pycnogenol® intragastrically exhibited decreased BROD, EROD
and MROD activities in liver microsomes from 6 mo and 20 mo animals (Figure
1 A, B). Compared to untreated controls, BROD and MROD activity were
inhibited by 58% and 55% respectively in liver microsomes from Pycnogenol®treated 6 mo animals and by 81% and 77% respectively in liver microsomes from
Pycnogenol®-treated 20 mo animals. MROD activity was inhibited by 70% in
lung microsomes from 6 mo rats treated with Pycnogenol® and by 55% in lung
microsomes from 20 mo animals. Pycnogenol® treatment produced an increase
of 34-44% in EROD activity in lung microsomes (Figure 2A, B). The effect on
EROD activity in lung microsomes agrees with results obtained from the in vitro
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studies of the effects of Pycnogenol® (Huynh and Teel, 1998). The reason for
the stimulating effect of Pycnogenol® on EROD activity is not known.
O-dealkylation is used to determine the activity of isoforms of cytochrome
P450 (Weaver et al, 1994). Antibody inhibition studies show that EROD is
catalyzed principally by CYP2C6 but also by CYP2A1 and CYP2C11 in
noninduced rat liver microsomes (Burke et al, 1994). CYP2B1 and CYP2C11
catalyze BROD whereas MROD is catalyzed mainly by constitutive CYP1A2 in
rat liver (Burke et al, 1994). Various exogenous and endogenous compounds
are substrates for cytochrome P450 isoforms including steroids, pesticides,
herbicides, therapeutic drugs, chemical mutagens/carcinogens and other
xenobiotics in the environment (Burke et al, 1994). Research reports describe
the modulatory effects of phytochemicals on enzyme systems including
cytochrome P450 and the activation/detoxification of their substrates. Our results
suggest that Pycnogenol® administration inhibited the catalytic activity of
cytochrome P450 isoforms associated with dealkylation of benzyloxyresorufin,
ethoxyresorufin and methoxyresorufin in rat liver microsomes. This includes
isoforms CYP2C6, CYP2C11, CYP1A2, CYP2A1, and CYP2B1 (Burke et al,
1994). Pycnogenol® inhibited CYP1A2 activity in lung microsomes of the F344
rat. In contrast, Pycnogenol® enhanced the cytochrome P450 isoforms in lung
microsomes that dealkylate ethoxyresorufin, mainly CYP2C6 but also CYP2A1
(Burke et al, 1994). Pycnogenol® did not exhibit an effect on CYP2B1 and
CYP2C11 in lung microsomes that are associated with dealkylation of
benzyloxyresorufin (Burke et al, 1994). These results suggest that Pycnogenol®
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has selective effects on different isoforms of cytochrome P450 and that
Pycnogenol® may alter the hepatic metabolism of substrates for CYP2C6, CYP
2C11, CYP1A2, CYP2A1 and CYP2B1. In addition, Pycnogenol® may alter lung
metabolism of substrates for CYP1A2, CYP2C6 and CYP2A1.
Glutathione-S-transferase (GST) is an important enzyme in the
detoxification of electrophilic compounds. Detoxification of such compounds can
prevent membrane damage by lipid peroxidation and DNA and protein damage
by nucleophilic attack (Ketterer and Christodoulides, 1994). Our study did not
indicate that Pycnogenol® treatment had a statistically significant effect on GST
activity in either rat lung or liver regardless of age. Our data however supports
previous findings showing that enzyme activity including cytochrome P450dependent metabolism declines with age (Ames et al, 1995; Guo et al, 1993;
Hilali et al, 1993; Kato and Takanaka, 1968).
In conclusion, our study shows that Pycnogenol® administered
intragastrically to F344 male rats altered the activity of isoforms of cytochrome
P450 involved in the O-dealkylation of benzyloxyresorufin, ethoxyresorufin and
methoxyresorufin in both lung and liver microsomes but had no effect on GST
activity. In contrast to the inhibition of BROD, EROD and MROD activity in liver
microsomes from both 6 mo and 20 mo rats, Pycnogenol® treatment enhanced
EROD activity in lung microsomes from animals in both age groups. Our data
suggest that Pycnogenol® may affect the metabolism of substrates for
cytochrome P450 isoforms CYP1A2, CYP2A1, CYP2B1, CYP2C6 and CYP2C11
and therefore the activation and detoxification of these substrates. Additional
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studies are essential to our understanding of the action of Pycnogenol® and to
knowing whether these actions include health-promoting properties since
Pycnogenol® is marketed in both the United States and in Europe for human
consumption in the absence of governmental regulation.
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SUMMARY
Our previous studies using pycnogenol indicated that this mixture of
flavonoids and polyphenols inhibited O-dealkylation of substrates in a dosedependent manner. O-dealkylation is mediated by cytochrome P450 (CYP)
enzymes. In vitro activity of ethoxyresorufin O-dealkylase (EROD), and
methoxyresorufin O-dealkylase (MROD) were inhibited in liver microsomes from
6 mo and 20 mo male F344 rats. In vitro activity of 7-benzyloxy-resorufun Odealkylase (BROD) was inhibited in liver microsomes from 6 mo rats as well as
from lung microsomes. EROD and MROD activities in the lung were increased.
BROD, EROD, and MROD are substrates for CYP 2B1,2C6, and 1A2,
respectively. Our study using lung and liver microsomes from rats pre-treated
with pycnogenol suggested a change in the pattern of enzyme activity. To
determine a correlation between cytochrome P450 enzyme activity and
cytochrome P450 protein expression, polyclonal antibodies against rat CYP1A2
and CYP2B1 were used in immunoblotting analysis (Western) to detect protein
levels. Our results indicated that expression of CYP1A2 in lung microsomes
from 6 mo and 20 mo rats was increased in rats treated with pycnogenol when
compared to untreated controls. Expression of CYP2B1 in lung microsomes
from 6 mo animals and in liver microsomes from 20 mo rats was not significantly
different from control groups. Results from the immunoblotting study did not
correlate with results of O-dealkylase activity in lung and liver microsomes from
pycnogenol-treated rats.
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INTRODUCTION
Cytochrome P450 (CYP) is a family of hemoprotein enzymes involved in
the biotransformation of various biological products and of many xenobiotics
(5,6,33)

. These microsomal enzymes are responsible for the metabolic activation of

many procarcinogens and drugs and for the deactivation of numerous mutagens
and other physiologic byproducts. Bioactivation reactions produce reactive
metabolites that may attack DNA and proteins to interfere with normal protein
functions, while deactivation reactions form water-soluble products that are
excretable following interaction with conjugating systems

(20,26)

Methoxyresorufin, ethoxyresorufin, and 7-benzyloxyresorufin are substrates
selectively dealkylated by CYP1A2, 2C6, and 2B1, respectively (3-31-33). Thus the
metabolic activity of these three CYP isoenzymes may be determined by utilizing
these specific substrates.
Dietary carcinogens, including nitrosamines, polycyclic aromatic
hydrocarbons, and heterocyclic amines, are metabolized by CYP enzymes.
Pulmonary and hepatic enzyme activities are modulated by various
phytochemicals, some of which constitute part of the human diet

(2,14,15,19,26,27)

Hepatic enzyme activities from rats treated with green tea showed an increase in
the activity of EROD, MROD, and pentoxyresorufin O-dealkylase (PROD) and a
decrease in p-nitrophenol hydroxylase and erythromycin N-demethylase (2).
Ellagic acid, a plant polyphenol found in fruits and nuts, was shown to
significantly inhibit CYP-catalyzed EROD and PROD activities and p-nitrophenol
hydroxylation (1). A component of garlic oil, diallyl sulfide, also inhibited
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metabolism mediated by CYP2E1

(15,24)

. CYP2E1 is involved in metabolizing

ethanol. Diallyl sulfide, capsaicin, resveratrol and other phytochemicals found in
the normal human diet were shown to inhibit CYP-linked enzyme activity

(26,27,28)

Our previous studies using pycnogenol indicated that it inhibited Odealkylation of substrates in a dose-dependent manner(12i14). Pycnogenol is a
mixture of polyphenolic compounds extracted from the bark of maritime pine
trees (Pinus maritima)(18). The complex mixture of flavonoids and polyphenols
found in pycnogenol contributes to many of its reported activities, such as
antioxidant effects and the scavenging superoxide anion and hydroxyl radicals in
retinal epithelium

(22,30)

. Pycnogenol also modulates the release of nitric oxide

from vascular endothelium, thus showing a potential therapeutic effect in
cardiovascular diseases (7-23'25). Pycnogenol inhibited metabolism of the
procarcinogen NNK, a tobacco-specific nitrosamine, in liver and lung microsomes
from 6 mo and 20 mo rats, suggesting a possible role in preventing DNA adduct
formation by NNK (13).
Because phytochemicals can modulate the activity of certain enzymes, it
is important to understand the effects of these compounds on biologic systems.
Immunoassay for protein expression (Western analysis) using
chemiluminescence is a relatively simple, economical, fast and non radioactive
procedure

(8,21,29,32)

. The focus of the present study was to determine protein

expression of CYP1A2 and CYP2B1 in liver and lung microsomes of male F344
rats to verify metabolic activity of CYP1A2 and CYP2B1.
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MATERIALS AND METHODS
Reagents
Polyclonal goat anti-rat CYP1A2 and goat anti-rat CYP2B1 antibodies
were purchased from Gentest Corp (Woburn, MA). Peroxidase-conjugated
mouse anti-goat IgG was purchased from Jackson Labs (West Grove, PA). All
other immunoblotting reagents were purchased from BioRad Labs (Hercules
CA) and Amersham Pharmacia Biotech (Piscataway, NJ).
Microsomal Preparations
Male F344 rats age 6 mo and 20 mo were purchased from Harland Labs
Inc. (Indianapolis, IN). The rats were housed under light- and temperaturecontrolled conditions and were provided water and rodent laboratory chow ad
libitum. Following acclimatization, the rats were administered intragastrically 5
mg pycnogenol/kg body weight in saline once each day for three consecutive
days. Twelve hr after the last intragastric dose, the animals were sacrificed and
the livers and lungs were removed and transferred to ice-cold 0.1 M Tris-HCI
buffer (pH 7.4). The organs were minced and homogenized and microsomes
were prepared by differential centrifugation (17). Cytosol and microsomal protein
contents were determined (16). One-ml aliquots of the cytosol and microsomal
fractions were stored at -80° C prior to use in Western blotting analysis.
Immunoblotting
Immunoblotting analysis was modified from Code et al{5). Briefly, the
samples were prepared by addition of equal amounts of microsomal protein to
equal volumes of Laemmli sample buffer (BioRad). Samples were heated for 5
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min at 90° C, then loaded onto a 10-20% Tris-HCI precast polyacrylamide gel
(BioRad) and electrophoresed at 150 kV for 70 min in a Mini-Protean (BioRad)
electrophoresis module. Proteins were transferred onto PVDF membrane by
electroblotting at room temperature at 15 V for 30 min. The membrane was
blocked in 7% milk in phosphate buffered saline (PBS) containing 0.05% Tween
20 (blocking buffer) for 4 hr. The membrane was then incubated with anti-rat
CYP1A2 (diluted 1:5000) or anti-rat CYP2B1 (diluted 1:7500) polyclonal
antibodies in blocking buffer overnight at 4° C. The primary antibody and
blocking buffer were rinsed from the membrane 3 times for 5 min each in
PBS/Tween 20. The membrane was incubated with horseradish peroxidaseconjugated anti-goat IgG (diluted 1:7500) in PBS for 1 hr at room temperature,
followed by another rinsing 3 times for 5 min each in PBS/Tween 20. Enhanced
chemiluminescence was used to analyze the bands according to manufacturer’s
protocol (Amersham Pharmacia Biotech). Relative protein content was
determined by densitometry of the developed autoradiographic films.
Statistical Analysis
Data plotted on the graphs are relative intensity of optical density as
determined by densitometry. Results are from duplicated experiments. Lung
samples were pooled from three animals of each age group (n = 6). Liver
samples were from 6 individual 20 mo rats. Comparison of treated and untreated
groups was determined by the student’s t-test. Significance was defined as p <
0.05 compared to control values.
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RESULTS
Immunodetection of CYP 2B1 in Rat Liver and Lung Microsomes
Polyclonal antibodies against CYP2B1 were used to determine the
expression of CYP2B1 in liver microsomes from 20 mo rats as well as in lung
microsomes from 6 mo animals. CYP2B1 is involved in the metabolism of NNK
(10)

. Expression of CYP2B1 in liver microsomes from 20 mo rats treated with

pycnogenol was not significantly different from untreated group (Figure 1). In
lung microsomes from 6 mo rats, expression of CYP2B1 was reduced in the
presence of pycnogenol, however extent of the reduction was not significantly
different from the untreated rats (Figure 2). Protein content of samples from 20
mo rat liver microsomes was 12.5-16 mg/ml and from 6 mo rat lung microsomes
was 4-8.5 mg/ml.

111

12
10
.ti

w
c
o

o
PO

8

6

TJ
0)

2

O)
0)

4

2

0
Control

Pyc-treated

Figure 1. Expression of CYP2B1 in liver microsomes from 20 mo
rats. Data was taken from duplicate experiments using six individual
animals. Ten jag of liver microsomal protein was loaded into each
sample lane of the SDS-PAGE gel. The gel was incubated in a
blocking solution containing anti-rat CYP2B1 (Gentest Corp.) at a
dilution of 1:7500 overnight at 4° C before incubation with secondary
antibody (diluted 1:5000). Procedural detail is given in Materials and
Method. There was no significant difference between pycnogenoltreated animals and controls, p > 0.05.
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Figure 2. Expression of CYP2B1 in lung microsomes from 6 mo
rats. Data was taken from duplicate experiments using 6
individual animals. Ten pg of lung microsomal protein was
loaded into each sample lane of the SDS-PAGE gel. The gel
was incubated in a blocking solution containing anti-rat CYP2B1
(Gentest Corp.) at a dilution of 1:7500 overnight at 4° C before
incubation with secondary antibody (diluted 1:5000). Procedural
detail is given in Materials and Methods. There was no
statistically significant difference between pycnogenol-treated
animals and controls, p > 0.05.
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Immunodetection of CYP 1A2 in Rat Lung Microsomes
We have previously shown that following intragastric administration to
rats, pycnogenol effectively inhibited the metabolism of methoxyresorufin in lung
and liver of 6 mo and 20 mo male F344 rats. Methoxyresorufin is a substrate
commonly used to selectively determine the metabolic activity of CYP1A2
enzyme (2,3). Immunoblotting analysis of lung microsomes using polyclonal
antibodies against CYP1A2 indicated a significant increase in the expression of
CYP1A2 in pycnogenol-treated 6 mo rats compared to the untreated group
(Figure 3). Analysis of lung microsomes from 20 mo rats showed an increase in
the expression of CYP1A2 in the pycnogenol-treated animals, however this
increase was not significantly different from the untreated samples. The protein
content in lung microsomes from 6 mo animals was 4-8.5 mg/ml and 6-10 mg/ml
from 20 mo animals.

DISCUSSION
Our previous work utilizing pycnogenol showed that this mixture of
polyphenols and flavonoids was capable of inhibiting cytochrome P450 metabolic
activity, both in vivo and in vitro, in liver and lung microsomes prepared from 6
mo and 20 mo old male F344 rats. In liver microsomes from both age groups,
pycnogenol inhibited cytochrome P450-linked O-dealkylation of ethoxyresorufin
(EROD) and methoxyresorufin (MROD), the substrates for CYP 2C6 and 1A2
respectively

(12,14)

. However, the effect of pycnogenol on the O-dealkylation of

benzyloxyresorufin (BROD) activity

114

2.5 t
□ Control
Hi Pyc-treated
»2-0
.ti

w
c

0)

Q

To 1-5
o
4^

*

Q.

o

l

"S i.o
To

U)

iisti::

0)

c

0.5

0.0
6 Mo Lung

20 Mo Lung

Figure 3. Expression of CYP1A2 in lung microsomes from 6 mo
and 20 mo rats. Data was taken from duplicate experiments using
6 individual animals. Sixty pg of lung microsomal protein was
loaded into each sample lane of the SDS-PAGE gel. The gel was
incubated in a blocking solution containing anti-rat CYP1A2
(Gentest Corp.) at a dilution of 1:5000 overnight at 4° C before
incubation with secondary antibody (diluted 1:5000). Procedural
detail is given in Materials and Methods. Asterisks indicate
statistically significant difference from control animals, p < 0.05.
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in liver microsomes from 20 mo rats was not significantly altered in the in vitro
studies. CYP2B1 is linked to BROD activity (3). We proceeded to determine
protein expression of CYP2B1 in liver microsomal samples from 20 mo rats
administered pycnogenol. Results from immunoblotting analysis of these
samples indicated no appreciable change, when comparing pycnogenol-treated
animals to the untreated controls, in the expression of CYP2B1 (Figure 1).
These results do not explain the inhibitory effect of pycnogenol on BROD activity
in liver microsomes from 20 mo rats administered pycnogenol.
In the in vitro studies of lung microsomal samples from both 6 mo and 20
mo rats, pycnogenol increased EROD and MROD activities and decreased
BROD activity (12). In the in vivo studies, intragastrically administered pycnogenol
increased EROD activity and decreased BROD and MROD activities (14).
Because of the discrepancy in the effect of pycnogenol on BROD and MROD
activity, we utilized immunoblotting analysis to determine if there was a change in
the protein expression of CYP 2B1 and 1A2, the enzymes involved in the
dealkylation of benzyloxyresorufin and methoxyresorufin, respectively.
Our enzyme activity studies comparing pycnogenol-fed rats to the
untreated control groups showed no change in BROD activity in lung microsomes
in 6 mo rats (14). However BROD activity was decreased in the 20 mo
pycnogenol-fed rats (14), as well as in lung microsomes from 6 mo and 20 mo
animals not given pycnogenol(12). Results from the immunoblotting analysis of
CYP2B1 in lung microsomes from 6 mo rats showed a decrease in protein
expression in pycnogenol-fed animals compared to controls (Figure 2). Although
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the immunoblotting data showed no statistically significant difference, the results
do show a trend of decreased protein expression with pycnogenol treatment
which supports our findings in both the in vivo and in vitro studies.
Results of immunoblotting analysis of lung microsomes from 6 mo and 20
mo rats administered pycnogenol indicated an increase in the expression of
CYP1A2 protein in the presence of pycnogenol (Figure 3). The increase seen in
the 6 mo animals was statistically significant from the untreated control groups
whereas in the 20 mo rats, the increase was not statistically significant (Figure 3).
These results do not explain the effects of MROD activity in vitro and in vivo.
Previous work by other authors indicated that one of the advantages of
using Western blotting analysis is its high sensitivity

(8,32)

. However, in our

current study, we utilized polyclonal primary antibodies to identify CYP1A2 and
CYP2B1. The use of polyclonal antibodies may compromise the sensitivity of
Western analysis because these polyclonal antibodies exhibit cross-reactivity
with other CYP isoenzymes (11).
Several potential problems may arise during Western blotting procedure.
Incomplete or poor transfer of proteins from the gel to nitrocellulose or PVDF
membrane can result in skewed or distorted bands upon visualization. Such
distortion may be reduced or prevented by ensuring good initial contact between
the gel and the membrane (4) and by excluding air bubbles between the gel and
the membrane in the semi-dry blotting systems (11). Use of appropriate buffer
may improve protein transfer. Methanol is often added to the transfer buffer to
increase binding of proteins to membrane, to reduce gel swelling, and to aid in
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cooling the gel during the transfer(11). However, methanol may contract pores of
the gel and reduce elution of proteins (11).
Another source of potential problem encountered in Western blotting is the
denaturation of proteins if left for an extensive time period during the heating
process (11). Monoclonal antibodies often fail to react in Western blotting
because they bind with conformation-insensitive epitopes and should these
epitopes become inactive, there would be no immunoreaction to detect(11).
Polyclonal antibodies on the other hand can interact with multiple epitopes that
may be more resistant to denaturation by heating

(11)

Western blotting is a function of the antibody titer

(4,11)

. Because the sensitivity in
failure to detect antibody

signals should not be interpreted as an absence of the antibody or the protein
against which the antibody reacts.
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SUMMARY
Breast cancer is the second leading cause of cancer death in women in
the United States. The 1999 Cancer Facts and Figures, published by the
American Cancer Society, estimates that almost 43,700 women and men will die
of breast cancer in the United States. In this study, we compared the response
of human breast cancer cells (MCF-7) and normal human mammary cells (MCF10) to apoptosis in the presence of pycnogenol. Pycnogenol is a mixture of
flavonoid compounds extracted from the bark of pine trees. MCF-7 and MCF-10
cells were plated out in culture dishes and grown in medium containing 0, 40, or
80 jug pycnogenol/ml culture medium. Cells were harvested at confluency,
incubated with DARI for 15 min and viewed microscopically for evidence of
apoptosis. Apoptosis is detectable by morphology, chromatin condensation
nuclear DNA fragmentation, DNA strand breakage or apoptotic bodies. DARI is a
DNA-binding fluorescent dye used to visualize DNA fragmentation. Apoptosis,
as detected by DARI staining, was significantly higher in MCF-7 cells treated with
pycnogenol than the untreated cells. The presence of pycnogenol did not
significantly alter the number of apoptotic cells in MCF-10 samples. These
results suggest that pycnogenol selectively induced death in human mammary
cancer cells (MCF-7) and not in normal human mammary MCF-10 cells.
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INTRODUCTION
Apoptosis is a programmed cell death process that occurs during
embryogenesis and development (21). This loss of nonpathological cells may be
a mechanism to preserve homeostasis in animals as well as in plants. Under
nonpathological conditions, cell death may occur following an accumulation of
genetic mutations that normal DNA repair mechanisms fail to correct. Cell death
may also occur following extrinsic and intrinsic stimuli such as irradiation, viral
infection, chemotherapeutic agents, growth factor depletion, hypoxia, oxidants
and hormones (22). Recently, there has been an explosive increase in scientific
research of apoptotic mechanisms and regulation. The role of apoptosis in
cancer development is of particular interest because the regulation and/or
manipulation of apoptosis in tumor cells may become a potential cancer therapy.
Cells undergoing apoptosis have observable morphology expressed as
condensed chromatin, apoptotic bodies, and chromosomal DNA fragmentation
(9). The use of the DARI (4’-6-diamidino-2-phenylindole) DNA stain allows for
the detection of apoptotic cells under fluorescent microscopy. In the current
study, we utilized DARI staining method to determine the effect of pycnogenol, a
mixture of flavonoids extracted from marine pine bark, on apoptosis in human
mammary epithelial cells (MCF-10 and MCF-7 cells).
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MATERIALS AND METHODS
Cells
Dr. D. DeLeon (Dept. Phys/Pharm., LLU) generously provided human
mammary epithelial cells (MCF-10 and MCF-7) utilized in this study. MCF-10
cells were cultured in DMEM/F-12 medium (HyClone Labs, Logan, UT)
supplemented with 2.4 g/L NaHCOa, 1% penicillin-streptomycin solution (Cat # P0781), 10 jiig/ml insulin, 500 ng/ml hydrocortisone, 100 ng/ml cholera toxin, 2%
glutamine, and 5% horse serum (Sigma Chemical Co, St. Louis, MO) and 20
ng/ml murine EGF (Life Technologies, Inc, Grand Island, NY). MCF-7 cells were
cultured in DMEM/F-12 medium (HyClone Labs, Logan, UT) supplemented with
1.2 g/L NaHC03, 0.1% gentamicin, 1% Penicillin-Streptomycin antibiotic, and 2%
glutamine (Sigma Chemical Co, St. Louis, MO) and 2% fetal bovine serum
(HyClone Labs, Logan, UT). The cells were routinely grown in a humidified
atmosphere of 5% C02 at 37° C.
Cytochemistry
MCF-10 and MCF-7 cells were grown in 60 mm culture dishes containing
0, 40, or 80 pg/ml of pycnogenol (Dr. B. Lau, Dept. Micro, LLU). Pycnogenol was
prepared fresh and was filter sterilized prior to use in each experiment. Cells
were grown for 48-72 hrs until confluency. The cells were mechanically
harvested and centrifuged at 1500 X G for 10 min. The cells were rinsed in PBS
and recentrifuged. One ml DAPI (Sigma Chemical Co, St. Louis, MO) at a
concentration of 1 ng/ml in methanol was added to each tube containing the
cells. The cells were protected from light and stored at 4° C for 15 min.
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Following the incubation period, the cells were washed in PBS and centrifuged at
1500 X G for 10 min. The cells were then suspended in mounting media (1 part
glycerol to 2 parts PBS) and samples were prepared on microscope slides. Cells
were viewed and counted using an Olympus BX50 microscope equipped with
SPOT (Diagnostic Instruments, Inc.) camera and analytical computer software
(Vers. 1.2.1).
Statistical Analysis
100-300 cells were counted on each microscope slide. The apoptosis
index is the percent of apoptotic cells per the total number of cells counted.
Values reported are the average from 10 separate experiments for each cell line.
Statistical significance is defined as p < 0.05.

RESULTS AND DISCUSSION
MCF-10 cells were derived from human fibrocystic mammary epithelial
tissue and have characteristics of normal breast epithelium. These cells lack
tumorigenic activity in nude mice, display three-dimensional growth in collagen
grow in hormone- and growth factor-dependent culture, and lack anchorageindependent growth (20). MCF-7 cells were derived from a patient exhibiting
metastatic breast cancer (10). Early studies of MCF-7 cells show that estrogen
directly stimulates growth of this tumor cell line while the antiestrogen tamoxifen
reversibly inhibits MCF-7 cell growth (10).
1,25-dihydroxyvitamin D3 (vitamin D3) is the active form of the hormone
that regulates calcium homeostasis and that plays a role in the proliferation and
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FIGURE 2. The apoptosis index of MCF-7 cells grown in culture
media containing 0, 40, or 80 p,g/ml pycnogenol. Data reported is
the mean ± SEM of 10 separate experiments. Asterisk indicates
statistical significance, defined as p < 0.05 compared to control.
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differentiation of malignant cell lines (12). Vitamin D3 and its synthetic analogues
induce apoptosis in breast cancer, colon cancer, and glioma cell lines (12).
Induction of apoptosis in the breast cancer cell line was shown to be independent
of caspase and p53 activation. However, vitamin D3-induced apoptosis in the
MCF-7 cell line may involve the down-regulation of bcl-2 (12) or the disruption of
estrogen dependent signaling pathway (18). Curcumin, a commonly used spice
induces apoptosis in MCF-7 cells by inhibiting cell proliferation, causing cell cycle
arrest, down-regulating p53 gene and up-regulating Bax gene (16, 19).
Pycnogenol is a mixture of compounds extracted from the bark of pine
trees (Pinus maritima). A chromatographic profile of pycnogenol has revealed
that this mixture is composed of phenolic, procyanidin/proanthocyanidin, and
flavonoid compounds existing as monomers, dimers, and oligomers of five to
seven units (13). The oligomers are composed mainly of catechin and
epicatechin units linked together by 4-8 or 4-6 bonds (13, 17). Other minor
constituents of pycnogenol include phenolic acids and glucosides and glucose
esters (13, 17). Pycnogenol lacks toxicity (pharmacologic LD5o is 3 g per kg per
os) and is nonteratogenic and nonmutagenic (11).
Scientific data suggest that the effects of pycnogenol are widespread.
Effects of pycnogenol (at various concentration from 0 to 240 |ig/ml) on rat
microsomal enzyme activity include inhibition of metabolism of the tobaccospecific nitrosamine, NNK (5, 6) and modulation of cytochrome P450 enzymes
(7, 8). Various investigators have shown pycnogenol to scavenge cytotoxic free
radicals (13 and references therein) and can induce relaxation of the vascular
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bed in human subjects (23). In 1984, Schmidtke et al showed that a single dose
of pycnogenol (360 mg) improved capillary resistance and swelling in the legs,
indicating a potential use for pycnogenol to treat varicose veins and chronic
venous insufficiency (23). Cigarette smoking induces platelet aggregation, which
can lead to thrombus formation (15). In stroke patients, a single 200 mg dose of
pycnogenol prevented smoking-induced platelet aggregation and the effect of
pycnogenol persisted for more than 6 days posttreatment (15, 23). Fitzpatrick et
al demonstrated that addition of 10 |ng/ml pycnogenol caused relaxation of
precontracted rat aortic rings, an effect not observed in deendothelialized tissue
(2). Because superoxide radical can inactivate nitric oxide (NO), Fitzpatrick et al
have suggested that pycnogenol may induce vasorelaxation by inducing radical
scavenging enzymes such as SOD and catalase and by inactivating free
radicals, including superoxide.
In the current study, addition of 40 jug/ml or 80 pg/ml pycnogenol to growth
medium of MCF-10 cells did not result in significant changes in the apoptosis
index (Figure 1). The apoptosis index of MCF-10 cells grown in medium
containing pycnogenol decreased in a concentration-dependent manner although
the effect was not statistically significant. The apoptosis index of MCF-7 cells
increased in a concentration-dependent manner in cultures treated with
pycnogenol, which was statistically significant at a concentration of 80 |ng/ml
pycnogenol (Figure 2). It was noted that in the absence of pycnogenol (0 |ig/ml)
MCF-10 cells showed a higher apoptosis index than in the untreated MCF-7
cells.
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Expanding research interest into the importance of plant-derived
compounds has provided evidence that some phytochemicals are
chemopreventive agents. Green tea is a widely consumed beverage that was
first introduced to Europe from China by Dutch traders (3, 24). Exposure of
green tea polyphenols to the A431 human epidermal carcinoma cell line and to
prostate cancer cell lines resulted in the formation of DNA fragments (1, 14)
which is a hallmark of apoptosis (9). DNA fragments are detectable
morphologically and by nuclear staining when visualized by gel electrophoresis
and fluorescense microscopy. Isothiocyanates (ITC) are strong chemopreventive
agents present in cruciferous vegetables such as broccoli, cabbage, and radish
(4). Previous studies have shown ITCs to decrease NNK-induced lung tumors in
F344 rats and in A/J mice (25) and to inhibit the activity of certain cytochrome
P450 enzymes (4, 25). Recently, ITCs were shown to induce apoptosis in HeLa
cells via induction of caspase 3 and cleavage of PARP (poly-(ADP-ribose)
polymerase) (25). Induction of apoptosis by isothiocyanates may also be
dependent on activation of p53 (4).
An increased public interest in the use of and the unregulated marketing of
phytochemicals such as Gingko biloba, ginseng and garlic warrants research and
investigation into the physical properties, physiological mechanisms and
biochemical activities and interactions of phytochemicals. Pycnogenol is widely
marketed in Europe and in the United States as a nutritional supplement. In the
United States, nutritional supplements are basically immune from governmental
regulation. Pycnogenol is marketed and consumed for its antioxidant and free
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radical scavenging effects. Because there are limited scientific data available on
the effects of pycnogenol and on its mechanisms of action, we investigated the
effect of pycnogenol on apoptosis. Our results suggest that pycnogenol
selectively induced cell death in the human mammary cancer cells (MCF-7), and
not in normal human mammary MCF-10 cells. Further research is essential to
gain an understanding of the mechanism(s) by which pycnogenol induces
apoptosis in MCF-7 cells.
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CHAPTER 8
DISCUSSION
Phytochemicals are naturally-occurring compounds found in plants, many
of which are consumed as nutritional supplements by humans. Plants are a
source of many pharmaceutical agents currently used to treat human diseases.
Digitalis (from the foxglove flower Digitalis purpurea) and quinidine (from the
tropical plant Cinchona pubescens) are effective drugs to treat symptoms of
congestive heart failure (6). Aspirin is commonly used as an analgesic and anti
inflammatory agent. The active compound in aspirin is acetylsalicylic acid, which
is derived from the willow plant Salix(5). Reserpine, from climbing shrub
Rauwolfia serpentina, is used to treat hypertension (9). Anticancer agents, such
as the vinca alkaloids vincristine and vinblastine, come from the leaves of
periwinkle flowers and are used in the treatment of lymphomas, while paclitaxel
is used to treat ovarian and lung cancers and comes from the slow-growing yew
tree Taxus brevifolia (1). Pycnogenol, a mixture of compounds extracted from
Pinus maritima, acts as a free radical scavenger and is capable of modulating
levels of nitric oxide to induce capillary resistance and vasorelaxation

(3,16)

To further characterize the biological activity of pycnogenol, we designed
experiments to study the effects of pycnogenol on the metabolic activation of a
lung carcinogen. In this study, we utilized liver and lung microsomes from 6 mo
and 20 mo old male F344 rats to determine the effect of pycnogenol on the
metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3pyridyl)-1-butanone (NNK). Microsomes were incubated with 3H-NNK in the
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presence of pycnogenol for 30 min, after which NNK metabolites in the
incubation mixture were isolated by HPLC. NNK requires metabolic activation by
cytochrome P450 (CYP) enzymes (6). There are three major pathways for
metabolizing NNK: NNK reduction, N-oxidation and a-hydroxylation. The first
two are detoxification pathways while hydroxylation of a carbons forms reactive
electrophilic species, which methylate and pyridyloxobutylate DNA. CYP
isoenzymes CYP2B1, 1A1, 1A2, 2D6, and 2E1 are involved in NNK metabolism
(5). In chapter 2, we present results of the in vitro effect of pycnogenol on the
metabolism of NNK. Our results indicate that pycnogenol inhibited the in vitro
metabolism of NNK by rat lung microsomes in a dose-dependent manner. The
most active pathway, a-hydroxylation, as well as NNK reduction and N-oxidation
were significantly inhibited in both 6 mo and 20 mo lung microsomes.
Pycnogenol inhibited NNK reduction, the major metabolic pathway in liver
microsomes, and a-hydroxylation in liver microsomes.
To determine whether in vitro effects of pycnogenol correlate with in vivo
effects, 6 mo and 20 mo old F344 rats were administered intragastric (i.g.) doses
of 5 mg pycnogenol/kg body weight once daily for three consecutive days. The
rats were sacrificed 12 hr after the last i.g. dose and microsomal fractions were
prepared from the lung and liver. In chapter 3, we present the effects of
intragastrically administered pycnogenol on NNK metabolism by rat lung and liver
microsomes. The results differ from the in vitro data presented in chapter 2 in
that N-oxidation was enhanced in lung microsomes by pycnogenol in both 6 mo
and 20 mo animals and a-hydroxylation was enhanced in liver microsomes in
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both age groups by pycnogenol. In both studies the metabolism of NNK was
more active in lung and liver microsomes from the 6 mo animals.
In chapter 4, we describe experiments utilizing fluorescence spectroscopy
to study the in vitro effect of pycnogenol on cytochrome P450 isoenzymes
involved in the metabolism of endogenous and exogenous substances including
NNK. Benzyloxyresorufin, 7-ethoxyresorufin and methoxyresorufin are selective
substrates for CYP2B1,2C6 and 1A2, respectively. CYP2B1 and 1A2 are
involved in NNK metabolism while CYP2C6 is involved in drug metabolism. Odealkylation of benzyloxyresorufin (BROD), 7-ethoxyresorufin (EROD), and
methoxyresorufin (MROD) were assayed by incubating 0.5 juM of each substrate
with varying in vitro concentrations of pycnogenol and microsomal protein from
liver and lung of 6 mo and 20 mo F344 rats. Pycnogenol significantly inhibited
BROD, EROD and MROD activity by liver microsomes in a dose-dependent
manner in 6 mo liver microsomes and inhibited EROD and MROD activity in 20
mo liver microsomes. Pycnogenol inhibited BROD activity but enhanced EROD
and MROD activity in both 6 mo and 20 mo lung microsomes. Our data suggests
that pycnogenol inhibited the in vitro activity of CYP2B1,2C6, and 1A2 in rat liver
microsomes. Pycnogenol inhibited the in vitro activity of CYP2B1 in lung
microsomes but enhanced the in vitro activity of CYP1A2 and 2C6 in lung
microsomes from both 6 mo and 20 mo animals.
The effects of intragastrically administered pycnogenol on Phase I and
Phase II in vitro enzyme activities were also studied and the results are reported
in chapter 5. Intragastrically administered pycnogenol (5 mg/kg body weight per
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day for 3 consecutive days) significantly inhibited BROD, EROD, and MROD
activities in liver microsomes from both 6 mo and 20 mo rats. These results
correlated with those presented in chapter 4. In lung microsomes from both age
groups, intragastrically administered pycnogenol inhibited MROD activity and
enhanced EROD activity. There was no statistically significant effect of
pycnogenol on BROD activity. Glutatione-S-transferase (GST) activity is a
marker of Phase II enzyme activity. Intragastrically administered pycnogenol had
no significant effect on GST activity in lung or liver from either 6 mo or 20 mo
F344 rats.
In the strictly in vitro studies, the inhibition of the metabolic pathways
involved in NNK metabolism in liver microsomes of both 6 mo and 20 mo F344
rats by pycnogenol correlated with the inhibition of BROD, EROD and MROD
activity. This suggests that pycnogenol inhibited CYP isoenzymes 2B1,2C6, and
1A2. In lung microsomes, however, the inhibition of NNK metabolism correlated
only with the inhibition of BROD activity indicating that only CYP2B1 was
inhibited. When pycnogenol was administered intragastrically to the rats, NNK
reduction, and N-oxidation in liver microsomes was inhibited and a small but
statistically significant increase in a-hydroxylation occurred. This effect was not
adequately explained by the inhibition of BROD, EROD and MROD activity seen
in liver microsomes of the 6 mo and 20 mo animals that were administered
pycnogenol intragastrically. In lung microsomes from these rats, the inhibition of
NNK reduction and a-hydroxylation of NNK correlated only with the pycnogenolassociated inhibition of MROD activity.
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In an attempt to explain the discrepancies observed in these studies, we
assayed for the expression of CYP1A2 and CYP2B1 protein in liver and lung
microsomes from untreated F344 male rats and from F344 rats that received
intragastric doses of pycnogenol. These results are given in chapter 6. Using
SDS-PAGE gel electrophoresis and polyclonal antibodies against rat CYP1A2
and 2B1, we assayed for the expression of these proteins. The expression of
CYP2B1 in pycnogenol-treated animals was not statistically significant from the
control animals. This suggests that any effect of intragastrically administered
pycnogenol on liver and lung CYP2B1 activity was unrelated to differences in the
expression of the CYP2B1 protein. On the other hand, treatment with
pycnogenol enhanced the expression of CYP1A2 in lung microsomes. The
increased expression of CYP1A2 in these microsomes did not correlate with the
pycnogenol-associated inhibition of a-hydroxylation of NNK or with the inhibition
of MROD activity in lung microsomes described in chapters 4 and 5. What then
could account for the discrepancies observed in our studies? One possible
explanation is that the pycnogenol was not administered to the rats at a
sufficiently high enough dose and/or that the duration of the treatment was too
short. The concentration of the pycnogenol in the animals would no doubt need
to reach an effective level. Pycnogenol is water-soluble (10). The bioavailability
and distribution of pycnogenol in the F344 rat is not known. Reports in the
literature indicate that it is relatively non-toxic

(9,10,12)

. HPLC analysis of urine

samples from volunteers who had orally ingested pycnogenol show three
compounds {12). The retention times of the three compounds did not match up
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with those of any of the known compounds in pycnogenol. The activity of these
metabolites has not been reported. Renal clearance of compounds in
pycnogenol could limit the observation of any therapeutic effects. Since
pycnogenol is a complex mixture of compounds, illucidating which specific
compounds in the mixture possess biological activity becomes a real challenge.
Differences in the effects of pycnogenol on liver and lung microsome activity in
the strictly in vitro studies and those occurring with microsomes from animals
administered pycnogenol would depend upon effects of the gut environment on
these compounds in pycnogenol. The effects of pycnogenol would also depend
upon absorption, biodistribution and clearance of the compounds in animals.
Apoptosis is a programmed cell death process and may be stimulated by
genetic factors or by external signals including irradiation and drugs. Apoptosis
is important in the regulation of cell number during embryogenesis and
development. It may also be important in the regulation of hyperplasia
(excessive proliferation of cells) and tumor growth. Apoptosis is detectable by
morphology, chromatin condensation, nuclear DNA fragments, membrane
blebbing, apoptotic bodies, translocation of phosphatidylserine, expression of
nuclear genes (be/and bax) and enzyme activity (caspases and poly-(ADPribose) polymerase)

(2,13,14)

. DNA fragments and cell membrane changes are

detectable by fluorescent dyes, including 4’-6-diamidino-2-phenylindole (DARI)
Hoechst 33258, and Annexin V (4’15’18).
In our study of the effect of pycnogenol on apoptosis (chapter 7), we
cultured normal (MCF-10) and tumorous (MCF-7) human mammary cells in
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medium containing varying concentrations of pycnogenol (0, 40, and 80 |ig/ml).
At confluence, cells were collected and stained with DARI prior to visualization
under a fluorescent microscope. The apoptosis index (the percent of apoptotic
cells per total number of cells counted) of MCF-10 cells was decreased although
the effect was not statistically significant. In comparison, MCF-7 cells had an
apoptosis index that increased with the concentration of pycnogenol. This effect
was statistically significant at a concentration of 80 jig/ml pycnogenol. We
observed that in the absence of pycnogenol (0 |ig/ml), MCF-7 cells showed a
lower apoptosis index than in the untreated MCF-10 cells. This supports
evidence that cancer cells tend to be resistant to cell death and are considered
immortalized (17).
In conclusion, results of the studies reported in chapters 2-7 indicate that
pycnogenol inhibited the in vitro metabolism of the tobacco-specific nitrosamine
NNK in F344 rat liver and lung microsomes in both 6 mo and 20 mo animals.
Pycnogenol also inhibited the in vitro dealkylation of benzyloxyresorufin (BROD)
ethoxyresorufin (EROD) and methoxyresorufin (MROD) in liver microsomes.
This suggests an inhibition of cytochrome P450 isoenzymes CYP2B1,2C6 and
1A2. In lung microsomes, however, pycnogenol inhibited only BROD activity and
enhanced EROD and MROD activity. When rats were administered pycnogenol
intragastrically, a-hydroxylation of NNK was enhanced by a small but statistically
significant amount in liver microsomes from both 6 mo and 20 mo animals. Lung
microsomes from these same animals expressed inhibition of NNK reduction in
both age groups, inhibition of a-hydroxylation of NNK in 20 mo animals and
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enhanced N-oxidation in both 6 mo and 20 mo rats. Liver microsomes from rats
that were given pycnogenol intragastrically expressed an inhibition of BROD,
EROD and MROD activity. This suggests an inhibition of CYP2B1,2C6 and 1A2
which is consistent with the results obtained from the in vitro study of chapter 4.
Lung microsomes from these same animals expressed an inhibition of MROD
activity and a stimulation of EROD activity. Enzyme activity was consistently
lower in microsomes from the older rats. Lastly, the apoptosis index was
increased in MCF-7 breast cancer cells when they were cultured in the presence
of pycnogenol whereas in normal MCF-10 breast cells, the index was not
affected. The results presented here indicate that pycnogenol modulated
microsomal cytochrome P450 activity and programmed cell death in cancer cells
suggesting that pycnogenol has chemopreventive properties. Additional studies
are needed before a complete assessment of the effects of pycnogenol on
biological systems can be made.

143

REFERENCES
1.

Chabner B.A., Allegra C.J., Curt G.A., and Calabresi P. Antineoplastic
agents, in “Goodman and Gilman’s The Pharmacologic Basis of
Therapeutics”, Hardman J.G., Limbird L.E. et al (eds.), New York: McGrawHill, 1996, pp 1233-1287.

2.

Collins J.A., Schandl C.A., Young K.K., Vesely J. and Willingham M.C.
(1997) Major DNA fragmentation is a late event in apoptosis. J. Histochem.
Cytochem., 45(7): 923-934.

3.

Fitzpatrick D.F., Bing B., and Rohdewald P. (1998) Endothelium-dependent
vascular effects of pycnogenol. J. Cardiovasc. Pharmac., 32: 509-515.

4.

Glinsky G.V., Glinsky V.V., Ivanova A.B., and Hueser C.J. (1997) Apoptosis
and metastasis: increased apoptosis resistance of metastatic cancer cells is
associated with the profound deficiency of apoptosis execution mechanisms.
Cancer Lett, 115: 185-193.

5.

Hecht S.S. (1996) Recent studies of mechanisms of bioactivation and
detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a
tobacco-specific lung carcinogen. Crit. Rev. Toxic., 26(2): 163-181.

6.

Hecht S.S. and Hoffman D. (1988) Tobacco-specific nitrosamines, an
important group of carcinogens in tobacco and tobacco smoke.
Carcinogenesis, 9: 875-884.

7.

Insel P.A. Analgesic-antipyretic and antiinflammatory agents and drugs
employed in the treatment of gout, in “Goodman and Gilman’s The
Pharmacologic Basis of Therapeutics”, Hardman J.G., Limbird L.E. et al
(eds.), New York: McGraw-Hill, 1996, pp 617-657.

8.

Kelly R.A. and Smith R.W. Pharmacological treatment of heart failure, in
“Goodman and Gilman’s The Pharmacologic Basis of Therapeutics”,
Hardman J.G., Limbird L.E. et al (eds.), New York: McGraw-Hill, 1996, pp
809-874.

9.

Masquelier J. Plant extract with a proanthocyanidins content as therapeutic
agent having radical scavenger effect and use thereof. United States Patent
no. 4,698,360, 1987.

10. Masquelier J., Michaud J., Laparra J., and Dumon M.C. (1979) Flavonoids
and pycnogenols. Internal J. Vit. Nutr. Res., 49: 307-311.

144

university library

LOMA LINDA, CALIFORNIA
11. Oates J.A. Antihypertensive agents and the drug therapy of hypertension, in
“Goodman and Gilman’s The Pharmacologic Basis of Therapeutics”,
Hardman J.G., Limbird L.E. et al (eds.), New York: McGraw-Hill, 1996, pp
780-808.
12. Rohdewald P. (1998) Pycnogenol, in "Flavonoids in health and disease"
Rice-Evans C. and Pacher L. (eds.) New York: Marcel Dekker, pp 405-419.
13. Stewart B.W. (1994) Mechanisms of apoptosis: integration of genetic,
biochemical, and cellular indicators. J. Nat. Cancer Inst., 86(17): 1286-1296.
14. Tarnowski B.I., Spinale F.G. and Nicholson J.H. (1991) DAPI as a useful
stain for nuclear quantitation. Biotech. Histochem., 66(6): 296-302.
15. van Engeland M., Ramaekers F.C.S., Schutte B. and Reutelingsperger
C.P.M. (1996) A novel assay to measure loss of plasma membrane
asymmetry during apoptosis of adherent cells in culture. Cytometry, 24: 131139.
16. Watson R.R. (1999) Reduction of cardiovascular disease risk factors by
French maritime pine bark extract. Cardiovasc. Rev. Report, June: 326-329.
17. Weinberg R.A. (1996) How cancer arises. Scientific American, 275(3): 32-40.
18. Zhang G., Gurtu V., Kain S.R., and Yan G. (1997) Early detection of
apoptosis using a fluorescent conjugate of Annexin V. BioTechniques, 23(3):
525-531.

145

